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ABSTRACT
Inclusion of Kinetic Proteomics in Multi-Omics Methods to Analyze
Calorie Restriction Effects on Aging
Richard Hajime Carson
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
One of the greatest risk factors for disease is advanced age. As the human lifespan has
increased, so too have the burdens of caring for an increasingly older population suffering from
rising rates of cardiovascular disease, kidney disease, diabetes, and dementia. The need for
improving medical technology and developing new therapies for age-related diseases is manifest.
Yet our understanding of the processes of aging and how to attenuate the effects of aging
remains incomplete. Various studies have established calorie restriction as a robust method for
extending lifespan in laboratory organisms; however the mechanism is a topic of much debate.
Advancing our understanding of calorie restriction holds promise for illuminating biochemical
processes involved in the aging process.
One of the best explanations for the lifespan extension benefits of calorie restriction is
that it improves cellular protein homeostasis (proteostasis), but because proteostasis is dynamic,
it can be difficult to measure. We developed a novel combined omics methodology integrating
kinetic proteomics, and applied it to a mouse model placed on calorie restriction. Our unbiased
approach integrating just three measurements (kinetic proteomics, quantitative proteomics, and
transcriptomics) enabled us to characterize the synthesis and degradation of thousands of
proteins, and determine that calorie restriction largely alters proteostasis by slowing global
protein synthesis post-transcriptionally. Validating our omics approach, we were able to
replicate many previous results found in the literature, demonstrating the differential regulation
of various protein ontologies in response to the nutrient stress of calorie restriction. Moreover,
we were able to detect differential degradation of the large and small ribosomal subunits under
calorie restriction, and proposed a model in which the rate of protein synthesis could be
attenuated by the depletion of the large ribosomal subunit relative to the small subunit.
The flexibility of our dynamic combined omics approach was demonstrated by the
expansion of measurements to include nucleic acids and lipids. Flux measurements of DNA,
ribosomal RNA, and lipids yielded cellular division rates, ribosome turnover, and lipid
metabolism insights, respectively. We also adapted this approach to two-dimensional tissue
imaging by DESI-MS in a proof-of-concept study to demonstrate its utility for studying regional
differences in metabolism. The future integration of metabolomics and lipidomics into our
combined omics approach would be facile, and add unprecedented depth to systems-wide studies
involving cellular metabolism. Applied to the regulation of cellular homeostasis in humans, this
has the potential to open new avenues for elucidating the etiology of aging, understanding the
pathology of age-related diseases, and identifying novel targets for therapeutics.
Keywords: proteostasis, aging, calorie restriction, dietary restriction, advanced glycation endproducts (AGEs), combined omics, multi-omics, kinetic proteomics
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INTRODUCTION
Aging
At its most basic, aging is the process of becoming older. This simple definition,
however, belies the complex processes that occur as an organism grows and changes throughout
life. At its most broad, aging can be applied to describe the entire life cycle, from birth to death,
encompassing all of the often-profound metamorphoses that occur in between. Therefore, for
simplicity, the term “aging” will be used here to describe those changes that occur after an
organism reaches maturity (adulthood) and declines towards the end of its life.
For human beings, this involves a complex series of changes in phenotype that are
generally associated with poorer health. Although the rate of the process varies by individual,
there are many unifying characteristics: weakening of the body due to loss of bone and muscle
mass, increased wrinkling as skin loses flexibility and depth, decay of eye sight and hearing, loss
of cognitive function, decreased ability to combat infections, and a dramatic increase in the risk
of age-related diseases such as cancer, cardiovascular disease, kidney disease, diabetes, and
dementia. Due to an overall increase in lifespan over the past 100 years resulting largely from
improvements in healthcare and nutrition, the average human being will now live almost twice as
long as at the beginning of the 20th century1. However, the cost is an aging society that is
dependent upon increasing amounts of health care. Alzheimer’s disease, a form of dementia that
primarily affects the elderly, alone was affecting an estimated 50 million people worldwide in
2018, costing over one trillion U. S. dollars; these numbers are expected to rise to over 150
million patients, costing over two trillion U. S. dollars by the year 20302. This has been
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described as unsustainable3, and has triggered accelerated research into treatments and cures for
these age-related conditions.
Basic research into many of these age-related diseases has revealed much about their
mechanisms and underlying causes, although there is still much to learn about how they are tied
to aging. Aging itself is not a well-understood process, with competing hypotheses about the
root causes and mechanisms of aging. In a landmark review article paying homage to Hanahan
and Weinberg’s seminal review “Hallmarks of Cancer”4,5, Lopez-Otin and colleagues detailed
“The Hallmarks of Aging”6; these are summarized in Table 1. The authors identify initiating
changes at the level of an individual cell (genomic instability, telomere attrition, epigenetic
alterations, and loss of proteostasis) as likely to be primary drivers of age-related damage, with
the other hallmarks being reactions to and complications of these effects.
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Table 1 Hallmarks of Aging (Lopez-Otin, et al, Cell, 2011)
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Proteostasis
As a proteomics research group, we have been primarily interested in the loss of
proteostasis as a unifying feature of aging across species. Proteostasis describes the balance of
biochemical pathways within the cell controlling protein synthesis, folding, processing, transport,
and degradation that maintain the appropriate concentrations of proteins in the correct
proportions necessary for the proper functioning of the cell. In short, proteostasis is the process
whereby the proteome of the cell, all of the proteins within the cell at any single time, is
maintained. As its definition implies, proteostasis is very complex, encompassing many
different processes. A review by Jonathan Labbadia and Richard I. Morimoto in 20157 laid out a
framework to organize the various cellular processes into a “proteostasis network” (PN)
composed of four basic areas: protein synthesis, protein folding, disaggregation, and degradation.
This framework is shown in Figure 1 below, along with some of the major cellular proteins and
structures involved in the proteostasis network. Here, I adopt this organizational scheme to
simplify the discussion of the basics of proteostasis and its regulation.

4

Figure 1: The Proteostasis Network. The maintenance of a functioning proteome requires thousands of
participants within the cell, which are collectively termed the proteostasis network (PN). In the figure above, the
major components of the PN are categorized and listed adjacent to the proteostatic processes in which they
participate.
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The first process involved in proteostasis is the synthesis of proteins, in which messenger
RNA (mRNA) is translated by the ribosome (Figure 1). This process necessitates the
cooperative action of numerous proteins, which provides opportunities for multiple levels of
proteostatic regulation. The first step in protein translation, initiation, begins with the binding of
the eIF4F complex to the mRNA in a cap-dependent process that recruits the 43S pre-initiation
complex, which includes the 40S ribosomal subunit8. After locating the start codon (AUG) of
the mRNA transcript, the 60S subunit is recruited, and translation begins8.
Under conditions of stress, the initiation of protein translation can be modulated by
components of the cellular integrated stress response system (ISR)9. eIF2α kinases
phosphorylate eIF2α (part of the 43S pre-initiation complex) in response to a variety of
conditions (e.g. Gcn2 activates and phosphorylates eIF2α in response to amino acid
deprivation9); this inhibits the formation of the 43S pre-initiation ternary complex, and reduces
cap-dependent protein translation8. Cap-dependent translation is also inhibited through eIF4-BP,
which under high nutrient conditions is phosphorylated by mTOR; if the activity of mTOR goes
down (e.g. in nutrient stress), non-phosphorylated eIF4-BP binds to eIF4 and inhibits the
formation of the 43S pre-initiation complex8. Simultaneously, the transcription factor ATF4
becomes up-regulated under stress, as part of a cap-independent protein translation process that
increases under conditions of cap-dependent translation repression8. This transcription factor
then promotes the expression of a number of genes that aid the cell in dealing with stress10,11.
Continuation of protein synthesis past the initiation step depends on transfer RNA
(tRNA) and the ribosome. Transfer RNA, the bridge between nucleic acids and proteins, is
necessary for carrying the proper amino acids to the ribosome for addition to the growing peptide
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chain. tRNA is typically heavily modified with diverse chemical modifications, some of which
can be regulatory. For example, under oxidative stress conditions, a 5-methylcytosine
modification in the anticodon of a tRNA that codes for leucine results in the preferential
translation of mRNAs enriched for UUG12. Other codon-specific modifications have been
observed to change the rate of protein translation, illustrating that changing the cytosolic pool of
tRNA can alter the kinetics of protein synthesis8. Reduction of the tRNA pool occurs through
endolytic cleavage under oxidative stress, which has the overall effect of slowing protein
translation13. Protein fidelity depends on the correct joining of amino acids to their
corresponding tRNAs, the responsibility of the amino-acyl tRNA synthetases. Stress conditions
can increase the misacylation of methionine tRNAs, decreasing translational fidelity14; however,
translational fidelity has been seen to inversely correlate with translational speed15, which
decreases under stress conditions. tRNA metabolism thus offers many opportunities for
proteostasis regulation.
As the ribosome is the only protein complex capable of translation, it forms a nexus for
general synthesis control of proteins in the cell. The cell spends an extraordinarily large share of
its resources (60% of total mRNA transcription in a yeast cell16) on the generation of ribosomes:
four transcripts of rRNA and ~80 ribosomal proteins per ribosome, with over 200 proteins
involved in ribosomal biogenesis. Assembly is tightly controlled and coordinated, within the
nucleus as well as in the cytosol, with final quality checking leading to targeting of defective preribosomes for degradation17. Regulation of ribosome biosynthesis is subject to signal
transduction pathways that respond to stresses in the cellular environment that necessitate
adjustment of the proteome. For example, the TOR pathway responds to nutrient stress by
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repressing translation of ribosomal proteins (in mammals) and transcription of rRNA and
ribosomal protein genes in yeast16.
Regulation of the mature ribosome can be accomplished in part through post-translational
modification (PTM) of the ribosomal proteins within the subunits. Although our understanding
of the full range of PTMs on the ribosome remains incomplete, notable examples have been
characterized18. Phosphorylation of the S6 ribosomal protein by S6 kinase (S6K), the activity of
which is largely regulated by mTOR, demonstrates that a change in nutrient state is reflected in
the PTM state of the ribosome, presumably for regulatory purposes (the precise effect of the S6
phosphorylation is not completely understood)18. The phosphorylation and subsequent release of
L13 from the ribosome can be induced by the activation of the innate immune response; the
increase in L13 concentration in the free ribosomal protein pool serves as a downstream
regulatory signal19. The phosphorylation of certain ribosomal proteins has been shown to
correlate with Parkinson’s disease20, suggesting that some PTMs of the ribosome may lead to
disease states, and reinforcing the potential of ribosomal regulation through PTMs.
Ubiquitylation, the attachment of ubiquitin to lysine residues, is another common PTM found on
ribosomal proteins; the level of ubiquitylation of the ribosomal proteins is dynamic, and changes
with processes such as the cell cycle and the unfolded protein response (UPR), when specific
proteins need to be upregulated while translation is globally slowed18.
The process of protein translation is constantly monitored while in progress, for example
by the ribosomal quality control complex (RQC), which reacts to ribosomes that have stalled
during translation; their defective polypeptide products are tagged for degradation, and the
ribosome is “rescued” through splitting into its subunits21. In other situations when the ribosome
is damaged or malfunctioning and needs to be recycled, the cell engages in ribophagy, the
8

degradation of ribosomes through autophagy (the process of autophagy is discussed in more
detail below)22. This results in the degradation of the entire ribosome; however, there is
evidence that ribosomal proteins can be replaced piece-meal in the ribosomal subunits, ensuring
high ribosome quality without the need to sacrifice the entire complex23. Maintenance of the
ribosome in this way has been shown to respond to dietary signaling23, indicating regulation in
response to cellular needs in order to maintain proteostasis.
Properly functioning ribosomes are also important for proteostasis because the kinetics of
translation affect the proper folding of proteins. The ribosome is known to vary its speed as it
moves along messenger RNA, going most slowly at rare codons24. During these slow-downs, it
is thought that nascent peptides emerging from the ribosome have more time to engage in proper
folding before subsequent domains are translated25; this may be necessary if further sections of
the protein sequence promote alternative folding or aggregation26,27. Proper folding of proteins is
also promoted by chaperones, which associate with the ribosome and engage in co-translational
folding, as well as interact with partially folded peptides elsewhere to promote proper folding
post-translationally7. For some proteins, transport of the partially folded state to complexes
called chaperonins (HSP60 family) is necessary before the protein can assume its properly folded
state and function28.
Chaperones are necessary components for maintaining a properly folded proteome posttranslationally. Some proteins function properly only in a narrow range of stability, and are
sensitive to changing cellular conditions and stresses29. Other proteins may have inherently
disordered regions that are prone to aggregation, or may only be stable when bound to the proper
substrate or intracellular surface29. The proper function of such proteins relies on the constant
monitoring and maintenance provided by the chaperone/chaperonin network of the cell.
9

Misfolded proteins within the cytosol are primarily recognized and bound by the small heat
shock proteins (sHSP’s)30, which prevent their premature aggregation before other chaperones
such as HSP70, HSP90, and DNAJ-HSP40, along with numerous co-chaperones, can attempt to
refold the proteins into their functional states31. However, some proteins that become misfolded
aggregate, which is generally deleterious to cellular health. Neurodegenerative diseases such as
Alzheimer’s disease are associated with the accumulation of toxic insoluble protein aggregates
within cells7. Chaperones play a beneficial role here as well, either in the attempted
disaggregation of protein aggregates32, or by sequestering such aggregated proteins into more
benign structures called aggresomes for later processing33.
Proteins eventually outlive their usefulness, become damaged, aggregate, or undergo
recycling for raw materials. The two main processes used by the cell to degrade proteins are the
ubiquitin-proteosome system (UPS) and autophagy34. A coordinated system of E1 ubiquitinactivating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases are tasked with
identifying misfolded proteins, and tagging them with ubiquitin35. These proteins are then
shuttled to the proteasome for degradation. The 26S proteasome consists of approximately 31
subunits, which are organized into a 20S barrel-shaped core capped by one or two 19S regulatory
units responsible for recognizing ubiquitinated proteins36. These proteins are then processed
through the proteasome, emerging as separated amino acids; the ubiquitin tags are also removed
for recycling by de-ubiquitylating enzymes (DUBs)35.
For large protein complexes, organelles, and protein aggregates too large for the
proteasome, degradation proceeds through autophagy34. There are three forms of autophagy:
The first, chaperone-mediated autophagy, requires that a chaperone, HSPA8/HSC70, recognize
the degradation target, transfer it to the lysosome, and then mediate the engulfing of the target by
10

the lysosome through binding of a lysosomal-associated membrane protein (LAMP2A)34. The
second, microautophagy, is characterized by direct engulfment of substrates by the lysosome
through small invaginations of the lysosomal membrane37. The third kind, and the one usually
referred to simply as “autophagy,” is macroautophagy, in which degradation substrates are
encapsulated in a double-membrane structure called the autophagosome, which later fuses with
the lysosome38. In all cases, the degradation of substrates is accomplished through the action of
lysosomal hydrolases34. Autophagy thus serves as a means to not only clear the cytosol of
unwanted, damaged, or possibly toxic structures, but also to obtain new molecular building
blocks for cellular components34.
Breakdowns in any of the component processes of the proteostatic network can result in
disease. Mutations in chaperone-coding genes have been documented as causing a wide range of
conditions: Defects in heat-shock proteins can cause cataracts (-crystallin39), spastic paraplegia
(HSP6040), myopathy (-crystallin41), cardiomyopathy (-crystallin41), Charcot-Marie-Tooth
disease (HSP2242, HSP2743), and may also contribute to Parkinson’s disease (Mortalin44).
Malfunctions in other chaperones are associated with spastic ataxia (Sacsin41), cardiovascular
disease (HSC7045), motor neuropathy (HSJ146), and myopathy (DNAJB647). Further
downstream, mutations in protein degradation pathway components are associated with
amyotrophic lateral sclerosis or ALS (ubiquilin-248, p6249), spinocerebellar ataxia/MachadoJoseph disease (ataxin-350), Parkinson’s disease (Parkin51, RME852), Paget disease (VCP53,
p6249), frontotemporal dementia (VCP53), Nakajo-Nishimura syndrome (PSMB854), and
Angelman syndrome (UBE3A55). This is just a partial listing of known mutation-driven
conditions, and does not include diseases resulting from other preconditions or causes. However,
they illustrate the wide range and severity of symptoms resulting from the malfunction of
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proteostatic machinery, and underscore the importance of proper proteome maintenance to the
overall health of the cell and organism. Therefore, it is important to understand how cells control
and regulate proteostasis. Manipulation of the proteostasis network control nodes within the cell
using chemical interventions may lead to treatments for many age-related diseases that are
currently difficult to manage or cure. Improvement of overall proteostasis may also lead to
extension of health and lifespan in organisms28.

Slowing the Aging Process: Calorie Restriction
Calorie restriction is the most reliable method known to researchers for extending
lifespan and improving overall health in laboratory animals56. Briefly, calorie restriction is the
reduction in overall consumption of calories without causing malnutrition56. Although the
reduction of food intake has been described to increase lifespan since ancient times57, the first
scientific study on calorie restriction without malnutrition was performed in rats in the early
1930s by McCay, C. M. et al58. Since this initial study, calorie restriction experiments have been
repeated in a wide variety of model organisms (Table 2). In rodents, it has been shown that a
significant reduction of daily caloric intake (up to 60%) can increase lifespan by as much as
50%56. While the specifics of these experiments vary, the common thread is that health and
longevity are improved in many different model organisms, suggesting that the mechanisms
behind calorie restriction are evolutionarily ancient and highly conserved59. Calorie restriction
thus represents one of the best phenomena for the study of aging.
Major findings from calorie restriction experiments in various organisms are summarized
in Table 2, below. Among the benefits in all of the organisms listed are extended lifespan and/or
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improved health. However, the magnitude of these benefits depends on modulating factors such
as genotype, dietary components, and the specifics of various different calorie restriction
regimens (Table 2 – Modulating Factors). Some genotypes of yeast, fruit fly, and rodent have
been shown to react less well to calorie restriction (even negatively) relative to the wild-type
(Table 2 – Exceptions), and closely related species to these laboratory models also vary in their
responses to calorie restriction. While these variations complicate the study of calorie
restriction, there is also opportunity to discover more about the mechanisms of calorie restriction
by studying the biochemical differences between varying responses.
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Table 2 Effects of Calorie Restriction in Various Organisms56, 60-71
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However, despite almost 100 years of active research, the exact causes of the calorie
restriction health and longevity benefits remain elusive56. Moreover, as these are broad and
complex phenotype readouts at the organismal level resulting from a broad dietary intervention
that is anticipated to have multiple organ- and tissue-dependent effects, the mechanisms behind
calorie restriction are likely to involve an interplay of multiple biochemical processes that may
be difficult to succinctly describe3. There has been progress: some key pathways and proteins
have been identified as actors in the phenomenon of calorie restriction.
The TOR (target of rapamycin) pathway has been shown to play a central role in the
regulation of longevity in many different model organisms72. In response to nutrient signalling
(such as dietary protein73), cellular energy levels, or stress, activated TOR stimulates protein
translation at the initiation and elongation steps72; activation of TOR has also been shown to
affect protein degradation through inhibition of autophagy73. Likewise, the inhibition of TOR
can lead to decreased protein translation and increased autophagy in the cell. Rapamycin
treatment or knock-downs of components of the TOR pathway have been shown to have
lifespan-lengthening effects in a variety of model organisms, including yeast, nematodes, fruit
flies, and mice73. Decreased TOR signaling downstream of calorie restriction may therefore play
an essential role in calorie restriction’s lifespan extension benefits.
The TOR pathway acts upon and is regulated by other proteins and protein complexes
that have also been implicated in the calorie restriction phenomenon. The insulin-IGF1 pathway
activates a series of kinases, one of which, Akt, activates TOR; other kinases also act on TOR
downstream targets such as S6K, which in turn phosphorylates the S6 ribosomal protein72.
Downstream of the insulin-IGF1 pathway are the FOXO class of transcription factors, which
have also been shown to be key in calorie restriction74. Low energy levels in the cell, such as
15

may result from calorie restriction, can activate the AMPK pathway, which inhibits TOR
activity73. The MAPK pathway, which responds to cellular stress, can synergize with TOR
signaling through activation of Mnk172. Nutrient-sensing sirtuins have also been implicated as
actors in calorie restriction75, and act broadly in many parts of the cell, including the AMPK
pathway76.
A common thread among all of these players is their effect on the regulation of
proteostasis. The decrease in protein translation due to lower mTOR signaling, from direct
sensing as well as the synergy of the insulin-IGF1, MAPK, and AMPK pathways, is expected to
result in several benefits to the cell. As protein translation rate slows, translational fidelity
increases15, resulting in higher quality proteins. The slower translational speed also means more
time for correct co-translational folding as the ribosome moves along the mRNA transcript25, a
process also aided by the up-regulation of chaperone and co-chaperone production triggered by
stress-induced transcription factors77. The depression of mTOR activity also leads to
upregulation of autophagy73, whereby the cell may improve the quality of its existing proteome
through the degradation of damaged organelles and protein aggregates. Thus, the improved
proteostasis resulting from the effects of these key players may be the direct cause of the health
and longevity benefits of calorie restriction15,78,79.
Effective calorie restriction regimens also turn out to be more complex than a simple
reduction of calories. Reports in the literature show that the benefits of calorie restriction can be
attenuated by shifting the balance of macronutrients in the diet, such as fat, carbohydrates, and
protein80. In particular, high protein diets have been shown to be less beneficial under calorie
restriction80,81. Dietary protein activates mTOR and other nutrient sensors in the cell, and may
thus trigger pathways that conflict with those providing calorie restriction benefits80.
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Another well-studied dietary attenuator of calorie restriction benefits are advanced
glycation end-products (AGEs), modified proteins formed from the reaction between proteins
and sugar82. These are commonly found in processed foods in Western diets, and have been
connected to a variety of diseases normally associated with aging (Table 3). One of the most
important researchers in this field, Dr. Helen Vlassara, has been researching the effects of AGEs
for over 30 years, and has contributed significantly to the understanding of the role of dietary
AGEs in diabetes, cardiovascular disease, Alzheimer’s disease, and other age-related diseases.
Dr. Vlassara’s group published a study in 2008 showing that AGEs largely negate the normal
health and lifespan-extending benefits of calorie restriction83. While the mechanism behind this
phenomenon is not completely understood, AGEs are known to interact with receptors of AGEs
(RAGE), which have downstream effects of increasing inflammation84. Chronic inflammation is
known to cause health problems85, and may be key in the cancellation of calorie restriction
benefits. The potential of AGEs to act as a singular dietary signal modifying the proteostasis
network in calorie restriction was the driving idea behind our AGE-modified calorie-restriction
experiments (Chapter 3): a systems-wide view provided by our combined omics approach held
promise as a way to elucidate pathways that lead to CR benefits, as well as reduce them through
AGEs.

17

Table 3. Impacts of Advanced Glycation End-Products (AGEs)86-90
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Calorie restriction, therefore, is not expected to be a simple one-dimensional dietary
signal that should yield a single set of predictable biochemical changes. Rather, it suggests that
aging can be adjusted through a variety of factors in the diet. Indeed, other studies have shown
that aging benefits can be also be gained through intermittent fasting91, high carbohydrate-low
protein diets80, and changes in feeding times and frequency92. This vastly expands the usefulness
of calorie restriction as a model for studying mechanisms of aging, as each perturbation to the
basic regimen should affect a variety of pathways in different ways, all of which will affect
aging. Analysis of proteostasis measurements and comparison between these dietary
adjustments is expected to be far more efficient in discerning mechanisms involved in aging than
studying basic calorie restriction alone.

Measurement of Proteostasis to Understand the Biochemistry of Aging
Because of its broad and complex nature, proteostasis is difficult to measure. How does
one quantify all of the processes necessary to maintain the entire proteome at any given time?
This will necessarily involve omics technologies, as, at present, these are the only methods that
attempt to simultaneously measure and characterize entire pools of biological molecules, such as
proteins, nucleic acids, and metabolites. At present, the goal of being able to completely
describe the intricacies of metabolism in the cell in vivo or in vitro remains elusive. But
important gains have been made.
The identification and quantification of all of the mRNA being produced in a cell at a
given time (transcriptomics) serves as a snapshot of all the genes that are active within a cell93.
As such, this can serve as a way of measuring gene expression. Methods for measuring the
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transcriptome (the entirety of the mRNA within a cell at any given time) include microarrays94,
which test for specific sequences in a targeted manner, and sequencing technologies, which
identify and quantify mRNA content in a de novo fashion93. Because of the direct relationship
between mRNA and protein synthesis, studies in gene expression frequently use transcriptomics
as a proxy for protein metabolism within a cell95. However, it has been shown that the levels of
mRNA and protein concentration do not always correlate well. For example, Steven Gygi and
colleagues in 1999 published a study in which they showed that yeast protein expression levels
could not be predicted from their mRNA levels, showing that protein concentrations could vary
by up to 20-fold with equivalent mRNA transcription96. This is understandable, since protein
metabolism is regulated on a variety of levels, and numerous processes will affect the proteome
past the stage of transcription96. Nonetheless, transcription is regulated tightly by the cell
through epigenetics97 as well as a variety of transcription factors98, which may either act longterm or short-term, and thus serves as an initial point of analysis in the description of
proteostasis.
To reliably measure the quantity and types of proteins in a cell, one must use proteomics.
This can be done very effectively using mass spectrometry; methods for the identification of
proteins from the m/z values in mass spectra continue to be developed, but some, such as the
“bottom-up” approach used in our study, are now considered routine96. In a “bottom-up”
approach, proteins are first degraded to peptides, which are then sequenced by analysis of mass
spectrometry fragmentation data; the amino acid sequences are then mapped via established
databases to their original proteins99. Methods also exist to measure the quantity of proteins
within mass spectrometry samples, which gives the option for measuring levels of protein
expression. Although label-free quantitation100 was available, to improve precision and accuracy
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in the quantitation methods, we incorporated C13-lysine-labeled liver as an internal reference into
our quantitative mass spectrometry samples; the ratio of experimental to heavy-labeled peptides
vastly simplified the comparison between different mass spectrometry runs101. These
measurements enabled us to accurately measure protein concentration changes between
experimental conditions, and formed an integral part of our analysis of proteostasis. Such
quantitative measurements are relatively standard in the proteomics field, and form the basis for
much of the research. However, one of the major weaknesses behind quantitative mass
spectrometry lies in the fact that it yields static results; each measurement is a snapshot of a
dynamic process, which limits its utility, and must be considered in any interpretation of the data.
Proteostasis governs a system that is in constant flux, as proteins are constantly cycled
through the proteostatic network29. Measurement of protein concentrations alone is therefore
insufficient to fully understand the processes in proteostasis; one must also measure the flux, or
rate of change in protein concentrations. Indeed, protein concentrations may remain constant
even as flux increases or decreases, as long as synthesis and degradation rates match. Kinetic
proteomics involves adaptations to standard proteomic experiments that enable the calculation of
protein turnover rates, which give a measurement of the flux of proteins through a cell’s
metabolic pathways. The underlying principle behind kinetic proteomics is to label the newly
synthesized proteins in a way that makes them distinguishable from older proteins, typically by
using a heavy isotope, and then tracking this change over time to calculate a rate constant102.
We chose deuterated water as our heavy-isotope source, which had the advantage of
incorporating deuterium into not only proteins within the cell, but all newly synthesized
biomolecules. In theory, this meant that we could calculate turnover rates for any biochemical
species of interest, in addition to proteins, and indeed we adapted our mass spectrometry
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protocols to calculate turnover rates of DNA (which serves as a proxy for cellular division rate)
and RNA (both total RNA and ribosomal RNA) without having to regenerate biological samples.
We also explored the kinetics of lipid metabolism within the brain in a proof-of-concept method
development using desorption by electrospray ionization mass spectrometry (DESI-MS). While
the results were limited due to technical constraints, we established the feasibility of kinetic
lipidomics and explored the possibility of expanding kinetic omic methods to two-dimensional
tissue imaging using mass spectrometry, which adds the attractive possibility of exploring
regional tissue differences in proteostasis within distinctly structured organs (for more details on
the DESI-MS method, see Chapter 4).
Omics methods can generate a wealth of data, and are valuable for answering distinct
questions about processes within cells, tissues, and organs. However, when combined in a
“multi-omics” manner to look at biological systems as a whole, the number of questions that can
be answered about metabolism within the cell expands significantly. For example, the study
completed by Rendleman, J. and collaborators, published in 2018, combined transcriptomics,
translatomics, proteomics, and RNA-protein interactomics103. In this work, the authors studied
the temporal changes that occurred in proteostatic regulation in human cervical cancer cells
under conditions of cellular stress caused by protein misfolding and oxidative stress. The
integration of their data methods revealed intricacies in the temporal regulation of many genes
controlled at multiple levels within the cell, including genes involved in the endoplasmic
reticulum unfolded protein response, mitochondrial energy production, and alternative splicing
of tRNA synthetases. Their Protein Expression Control Analysis (PECA) tool104 enabled them to
convert the data from their multiple omic sets into information on protein expression regulation,
allowing them to identify novel regulatory stress event signatures. They identified the regulation
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of protein synthesis as a key regulatory strategy, which reinforces our desire to incorporate
measurement of turnover into our study of proteostasis.
In our study, multi-omics revealed broad levels of regulation of the proteome in calorie
restriction, as well as distinct perturbations in the regulation of specific protein functional
groups. We used a simplified model of proteostasis (see Chapter 2, Figure 1) to incorporate our
kinetic, quantitative, and transcriptomic data in a kinetic model that enabled us to discern
regulatory changes in synthesis from changes in degradation for individual proteins and
pathways. Specifically, the concentration of a given protein in the cell can be described
classically as a balance between synthesis, degradation, and cellular division rates (see Chapter
2, Equation 1). If the cell is at homeostasis, the change in protein concentration can be assumed
to be zero, and the turnover rate of the protein is an average of the synthesis and degradation
rates (see Chapter 2, Equation 2). When these equations are combined and solved for the
synthesis and degradation constants, it follows that the rate constants for synthesis and
degradation can be calculated using three measurements: turnover rate (from kinetic proteomics),
protein concentration (from quantitative proteomics), and mRNA concentration (from
transcriptomics using RNA-Seq) (see Chapter 2, Equations 3 and 4). While this neglects one of
the key aspects of proteostasis, namely protein folding and quality control, it nonetheless
provides a very solid foundation for measuring and analyzing basic proteome maintenance in the
cell, and thus forms the basis for the present study.
In this dissertation, I will first present my research into the method development for the
multi-omics approach to measuring proteostasis, and its application to the calorie restriction
phenomenon. Next, I will present a study on attenuation of calorie restriction benefits through
the addition of dietary advanced glycation end-products (AGEs), which will utilize parallel
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methods and analysis to the basic calorie restriction study. And finally, I will report on my
contributions to applying kinetic methods to lipidomics, as well as spatially two-dimensional
mass spectrometry (desorption by electrospray ionization mass spectrometry, or DESI-MS),
methods which in the future may be incorporated into multi-omic studies to yield further insights
into the etiology of aging and how we can attenuate the process through therapeutic
interventions.
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CHAPTER 2
“Short-Term Dietary Restriction in Mice Elicits Significant Post-Transcriptional Regulation of
Proteostasis”
This chapter represents the bulk of my research work as a graduate student. While my
research goal was to investigate the biochemical effects of AGEs (advanced glycation endproducts) on calorie restriction (CR), it was necessary to establish the baseline effects of CR on
our model organism. It was also useful for MS and RNA-Seq method development, as well as
testing multiple data analysis methods for the integration and interpretation of the multiple omic
data. In these efforts, I was joined by Brad Naylor, a fellow graduate student in the Price Lab.
Brad Naylor was responsible for the mouse work for the mice on the high protein diets, and I
was responsible for the mouse work on the low protein diets. We pooled our data for this study
and both contributed to study design, experimental work, data analysis, and writing up of results.
In terms of specific aspects of the project, Brad performed the quant-MS SILAM experiment and
analysis, I did the RNA-Seq experiment and analysis, as well as the RNA motif analysis and RTqPCR experiments and analysis, and both of us did the kinetic proteomics, each on our
respective mouse cohorts. The final write-up of the study, which follows, contains much of
Brad’s input, including sections of the Introduction, Methods, and Results, wherein it is a bit
difficult to delineate our separate contributions, since we worked closely together on several
drafts of the research write-up over the years of the study. However, the final data analyses
(especially the Global vs. Selective analysis), the interpretation of the results, the preparation of
the final draft and figures, and the development of the differential ribosomal subunit degradation
model (see Discussion) were all performed by me, as Brad graduated from the lab prior to the
fulfillment of the project. We plan to submit a version of this manuscript for publication very
40

soon, with a comprehensive list of all those who contributed to this study; while my name will be
listed first, Brad Naylor will be either co-first or second author.
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Title
Short-Term Dietary Restriction in Mice Elicits Significant Post-Transcriptional Regulation of
Proteostasis
Abstract
Advanced age is characterized by decreased proteome quality, leading to increased risk
of age-related diseases. Dietary restriction is a proven intervention for increasing lifespan and
healthspan in laboratory animals; decades of study suggest that these benefits result from an
overall improvement in protein quality and maintenance. However, the mechanisms by which
the proteome control machinery is adjusted to do so remain incompletely understood. Using
cohorts of mice placed on dietary restriction with varying dietary perturbations, we performed an
analysis of kinetic and quantitative proteomic data combined with RNA-sequencing data to
investigate nodes of proteome control in vivo. Our data show that a general slowdown of protein
turnover results from dietary restriction, and that this is the result of shifts in post-transcriptional
regulation. Moreover, this global slowdown is complex and can be modulated by dietary protein
intake. Our results support a model in which the large and small subunits of the ribosome are
degraded at significantly different rates from each other under dietary restriction, perturbing their
normal stoichiometric ratio, and thereby decreasing protein translation in the cell. We speculate
that this may be the result of sequestration of the small ribosomal subunit in stress granules
formed during dietary restriction. Slower translation rates would naturally lead to improvements
in translational fidelity, ribosomal maintenance, and co-translational protein folding, which
would result in the improved proteome quality expected under dietary restriction conditions.
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Introduction
One of the hallmarks of aging is a general loss of proteostasis, which is the balance of
biochemical processes within a cell dealing with the synthesis, folding, modification, transport,
and degradation of the proteins necessary for life. Imbalances in proteostasis are known causes
of disease and aging; with an increasingly older population in much of the world, many agerelated diseases, such as cancer and neurodegeneration, have reached epidemic proportions1.
Designing successful interventions to reduce or stop the age related loss of health would benefit
from a comprehensive understanding of the regulatory processes responsible for maintaining
proteostasis in cells. Healthy cells maintain the quality and quantity of their proteins using many
finely tuned controls on epigenomic, transcription, translation, post-translational, and
degradation processes. Because cells are dynamic, specialized to their location within the body,
and responsive to changes in their environment, proteome maintenance is very complex, with
subtle differences in regulation for each protein or protein complex.
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Figure 1: Proteostasis Model. At its most basic, proteostasis can be conceptualized as an equilibrium between the
processes of protein synthesis and degradation (as well as cell division).
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Proteomic dynamics within the cell can be described with a simple generalizable model
(Figure 1) in which the quantity of each protein in the cell is maintained in a balance between the
processes of synthesis, degradation, and cell division. Understanding the regulation of
proteostasis therefore requires large-scale measurements of synthesis and degradation. However,
according to the model, we can begin to make deductions about the regulation of synthesis and
degradation for thousands of individual cellular proteins by integrating only four separate
measurements: protein turnover (kinetic proteomics), protein concentration (quantitative mass
spectrometry), mRNA concentration (RNA-Seq), and cellular division rate (see Methods: MultiOmics Data Analysis). This enables calculations of separate synthesis and degradation rate
constants for thousands of individual proteins in vivo and a more detailed study of proteostasis.
To study the perturbations in proteostasis that result from aging, we used a mouse model
on dietary restriction (DR) as our experimental group to compare with normal ad libitum (AL)
controls. Dietary restriction has been shown repeatedly to be the most robust method for
increasing lifespan in laboratory animals; it has also been shown to markedly decrease the
incidence of age-related diseases2. However, despite some recent insights and decades of study,
the mechanism behind dietary restriction remains controversial. The source of calories in dietary
restriction diets also appears to be important, as demonstrated in multiple studies3,4,5. For
example, an increase in dietary protein has been shown to attenuate the lifespan- and healthspanexpansion benefits of dietary restriction in a dose-dependent manner4. While this mechanism is
incompletely understood, signaling through nutrient sensors such as mTOR appears likely4. This
suggests that dietary restriction benefits, rather than resulting directly from bulk energy
reduction, may instead result from the activation of a distinct signaling network, one that can be
disrupted with conflicting dietary signals, such as increased dietary protein. Our goal in this
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study was to investigate the changes to the proteostasis control network associated with this
disruption.
We applied a combination of kinetic proteomics, quantitative proteomics, and
transcriptomics to investigate how regulation of many individual proteins (~1000) in the liver is
affected by dietary restriction with variable levels of dietary protein. Our data point to a general
slowing of protein synthesis under dietary restriction as a result of changes in post-transcriptional
regulation. Specific groups of proteins including mitochondrial, endoplasmic reticulum, and
secreted proteins escaped this global slowdown of protein synthesis due to selective regulation,
likely to gain survival benefits and maintain tissue/organ function. This regulation is complex,
affecting both protein synthesis and degradation machinery, and is affected by dietary protein
levels. We propose a model in which the large and small subunits of the ribosome experience
differential rates of degradation that are exaggerated under dietary restriction and high dietary
protein, reducing the stoichiometric ratio of the two ribosomal subunits, and consequently
decreasing protein translation. Decreased protein translation simultaneously lowers the synthetic
and energy burden on the cell, improves protein quality through multiple mechanisms, and
ultimately results in the improved cellular and organismal health observed in dietary restriction.
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Methods

Figure 2: Experimental workflow. Mice were fed experimental diets for 10 weeks, then labeled with D2O and
sacrificed at various time-points. Liver was collected and prepared for various analyses: RNA was extracted for
RNA-Seq, and protein was collected for Kinetic Proteomics, or mixed with SILAC standard for Quantitative
Proteomics
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Animal Handling:
Mouse Housing, Genotype, and Diet
All animal procedure protocols were approved by the Institutional Animal Care and Use
Committee (IACUC) of Brigham Young University. Housing for mice was provided in a
pathogen-free facility for the duration of the experiment. 10-week old C57/BL6 male mice were
purchased from Charles River Laboratory, and fed ad-libitum for one week after arrival to
acclimate to the facility. Mice were then randomly divided into ad-libitum (AL) and dietaryrestricted (DR) dietary cohort groups; the mice were housed individually to ensure equal access
to food. Low dietary protein (LP) cohort animals were fed NIH31 chow, and high dietary
protein (HP) cohort animals were fed Harlan Teklad8604 chow (LP and HP cohorts were
purchased and treated at different times for logistical reasons). AL animals had constant access
to food, and DR animals were fed daily a pellet of 3g ± .1g in size (65% of expected AL
consumption). Mice were weighed weekly during one of the daily feedings of DR animals to
monitor health and weight loss.
Metabolic Labeling
At 10 weeks, (except for the 0-day time points) the mice were given an intraperitoneal
bolus injection of sterile D2O saline at 35 µL/g body weight. This injection brought the mice up
to 5% Molar Percent Excess (MPE) deuterium as previously described6. Mice were then
provided drinking water containing 8% MPE to maintain the 5% MPE in the animals’ body
water.
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Euthanasia and Sample Collection
Mice were anesthetized with CO2 and then euthanized by cardiac puncture. Mice were
then immediately dissected and all tissues except for blood were flash frozen on solid CO2 and
then stored at -80°C. Blood was stored on ice until it could be centrifuged at 800 x g for 10
minutes at 4°C. The centrifugation separated serum and red blood cells, which were stored in
separate containers at -80°C.
The LP-AL and LP-DR cohorts had 9 mice each. The HP-AL cohort had 19 mice and the
HP-DR cohort had 20 mice. Due to the difference in cohort sizes, sacrifice times were different.
Two LP animals from each diet were sacrificed at each of these time points: 1 day, 3 days, 9
days and 27 days after bolus injection, with one animal from each group sacrificed without
receiving a bolus injection or any other D2O labeling. The HP mice had two animals sacrificed
at each of these time points: 9 hours, 1 day, 2 days, 4 days, 8 days, 16 days, and 32 days post
injection, with the 4, 8 and 32 day time-points each having a third sacrifice; 2 HP-AL, and 3 HPDR mice were sacrificed without deuterium injection.
Mitochondrial Respiration
Fresh liver tissue was quickly removed from exsanguinated mice and immediately placed
in ice-cold mitochondrial respiration buffer (MiR05: 0.5 mM EGTA, 10 mM KH2PO4, 3
mM MgCl2-6 H2O, 60 mM K-lactobionate, 20 mM HEPES, 110 mM Sucrose, 1 mg/ml fatty acid
free BSA, pH 7.1) and trimmed of connective tissue. Tissue was gently separated and
homogenized under a surgical scope (Olympus, ST) to particles of approximately 1 mg.
Homogenate was then transferred to a tube with chilled MiR05 and 50 μg/ml saponin and rocked
at 4 °C for 30 min, then washed in MiR05 at 4 °C for at least 15 min before use. High-resolution
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O2 consumption was determined at 37 °C using the Oroboros O2K Oxygraph. Before addition of
sample into respiration chambers, a baseline oxygen consumption rate was determined. After
addition of sample, the chambers were hyperoxygenated to ∼350 nmol/ml., and respiration was

determined according to the manufacturer’s protocol. Lastly, residual oxygen consumption was
measured by adding antimycin A (2.5 μM) to block complex III action, effectively stopping any
electron flow and providing a baseline respiration rate.
Kinetic Proteomic Methods
Measurement of MPE
Aliquots of serum were distilled in 2.0 mL screw cap tubes overnight in a 90°C sand
bath, and the distillates collected. The distillate was diluted 1:300 in ddH2O, and MPE of
deuterium was directly measured against a D2O standard curve using a cavity ring-down water
isotope analyzer (Los Gatos Research [LGR], Los Gatos, CA, USA) according to the published
method7.
Trypsin Digestion
Mouse liver tissue was placed in ammonium bicarbonate (ABC) (25 mM, pH 8.5) along
with protease inhibitor cocktail (Sigma) and homogenized using a MP Biomedicals FastPrep-24
bead homogenizer at 6 m/s for 60 seconds. Volumes were calculated to give approximately 10
mg/mL protein. Protein concentration was measured using a bicinchoninic acid (BCA) protein
assay (Thermo Fisher). 300-500 µg of protein were placed on 30 kDa centrifugal filters (VWR).
100 µL of a concentrated guanidine solution (6 M guanidine HCl, 100 mM Tris-HCl pH 8.5) was
added to each sample and centrifuged at 14,000 x g for 15 minutes. This guanidine wash was
repeated, and the flow-through discarded. Disulfide bonds were reduced using a 10 mM
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dithiothreitol/6 M guanidine HCl/100 mM Tris-HCl (pH 8.5) solution (100 µL total volume)
added directly to the filters, with an incubation of 1 hour at 60°C in a sand bath. After 5 minutes
of cooling, cysteine sulfhydryl groups were protected by reaction with iodoacetamide (IAM, 20
mM) for 60 minutes in the dark. Afterwards, the samples were centrifuged at 14,000 x g for 15
minutes, and the flow-through was discarded. The samples were washed twice with ABC (200
µL, centrifuged 15 minutes at 14,000 x g). Pierce MS-Grade trypsin was added (1:50 w:w) in
300 uL ABC to each sample, followed by incubation at 37°C overnight. Resulting peptides were
eluted by centrifugation at 14,000 x g for 30 minutes, followed by a wash with 100 µL of ABC
and an additional centrifugation for 30 minutes at 14,000 x g. Filters were discarded and the
filtrate was dried using a speedvac (Sorval); the dried samples were stored at 4°C until use.
HPLC Fractionation
Samples were re-suspended in 10 mM ammonium formate (LC-MS grade pH 9.5) before
fractionation using high pH C18 High Performance Liquid Chromatography (HPLC), which is
orthogonal to the low pH C18 chromatography used in “LC-MS Data Acquisition,” allowing for
improved protein coverage8. Fractionation was performed using the 1260 HPLC Infinity
(Agilent) and the Gemini 50 x 2.00 mm C18 column with 3µm beads and 110 angstrom pore
size. Peptides were eluted using a 10 mM ammonium formate (pH 9.5) H2O/acetonitrile gradient
from 3% B to 60% B over 40 minutes flowing at 1 mL/min. Buffer A was 97% H2O, 3%
acetonitrile, 10 mM ammonium formate pH 9.5. Buffer B was 10% H2O, 90% acetonitrile, 10
mM ammonium formate pH 9.5. 1 mL fractions were collected and pooled into 8 samples by
pooling every 8th fraction. For instance, fractions 2, 10, 18, and 26 were pooled into one
sample. Pooled fractions were dried with a speedvac, then resuspended in 200 µL of 80%
acetonitrile and decanted into a mass spectrometry vial. Samples were again dried with a
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speedvac and suspended in 40 µL of 3% acetonitrile 0.1% formic acid (all LC-MS grade) for
LC-MS analysis.
LC-MS Data Acquisition
Protein identification and kinetic acquisition were performed on the Agilent 6530 Q-ToF
mass spectrometer coupled to capillary and nanoflow Agilent 1260 HPLC using the chipcube
nano-spray source6,9. Peptides were eluted from the Agilent C18 Polaris chip at 300 nL/min
using an H2O-Acetonitrile gradient acidified to pH 4 by use of Pierce LC-MS grade formic acid.
Buffer A was 3% acetonitrile, 0.1% formic acid. Buffer B was 97% acetonitrile, 0.1% formic
acid. The elution gradient was as follows: 0 minutes, 100% A; 0.1 minutes, 95% A; 27 minutes,
40% A; this was followed by high percentage B column washing and low percentage B
equilibration. The Agilent 6530 Q-ToF mass spectrometer was run in 2 Ghz high dynamic range
mode. Protein identification runs were performed in MS/MS mode using collision-induced
dissociation (CID) with nitrogen gas. MS and MS/MS data were collected at a maximum rate of
4 spectra/second with CID fragmentation on the top 10 most abundant precursors. Dynamic
exclusion was set to 0.2 minutes. Kinetic acquisitions were performed in MS only mode and
collected at 1 spectra/second. MS only mode increases signal intensity, improves signal-tonoise, and gives more scan points per elution chromatogram, greatly enhancing isotopomer
analysis accuracy.
Data were also collected on the Orbitrap Fusion-Lumos mass spectrometer. Samples
were resuspended in 0.1% formic acid (Pierce LC-MS grade) in H2O (Optima grade Thermo
Fisher), and analyzed with a Thermo Lumos Tribrid (Orbitrap). Tryptic peptides were separated
using a reverse phase C18 column (Acclaim PepMap™ 100) and a Thermo Easy-Spray source.

52

Mobile phase for the liquid chromatography was 0.1% formic acid in H2O (Buffer A) and 0.1%
formic acid in 80% acetonitrile (Optima grade Thermo Fisher) with 20% H2O (Buffer B) on an
Easy-nLC 1200 HPLC system. Samples were eluted using a gradient of 5% B to 22% B over 85
minutes, 22% to 32% B over 15 minutes, and a wash of 32% to 95% B over 10 minutes, which
was held at 95% B for 10 minutes. Sample loading and equilibration were performed using the
HPLC’s built in methods. MS only runs were performed using 2400 V in the ion source, 60000
resolution with a scan range of 375-1700 m/z, 30% RF Lens, quadrupole isolation, 8 *10^5 AGC
target, and a maximum injection time of 50 ms. MS/MS scans were performed using the same
settings as MS only scans, with 3 seconds allowed per MS/MS after each MS scan, using the
following filters: peptide monoisotopic peak determination, intensity threshold of 5*10^3,
fragmentation of charge states +2 to +6, dynamic exclusion that excluded a peak after being
chosen once within 60 seconds, an error tolerance of 10 ppm high and low, and isotopes
excluded. The fragmentation scan used an isolation window of 1.6 m/z, CID fragmentation with
an energy of 30%, detection in the linear ion trap in Rapid Scan mode with an AGC target of
1*10^4, a maximum injection time of 35 milliseconds, and used the “Inject Ions for All
Available Parallelizable Time” option.
Protein Identification
Peak lists obtained from MS/MS spectra were identified using Mascot version 2.2.04,
OMSSA version 2.1.9, X!Tandem version X! Tandem Sledgehammer (2013.09.01.1), MS-GF+
version Beta (v10282), Comet version 2016.01 rev. 2 and MyriMatch version 2.2.140. The
search was conducted using SearchGUI version 3.2.710. Protein identification was conducted
against a concatenated target/decoy version of the Mus musculus complement of the UniProtKB
(created September 2016, 16806 (target) sequences); decoy sequences were created by reversing
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the target sequences in SearchGUI. The identification settings were as follows: Trypsin,
Specific, with a maximum of 2 missed cleavages 10.0 ppm as MS1 and 0.5 Da as MS2
tolerances; fixed modifications: Carbamidomethylation of C (+57.021464 Da); variable
modifications: Oxidation of M (+15.994915 Da), Pyrolidone from Q (--17.026549 Da),
Acetylation of protein N-term (+42.010565 Da), Pyrolidone from E (--18.010565 Da),
Pyrolidone from carbamidomethylated C (--17.026549 Da); fixed modifications during
refinement procedure: Carbamidomethylation of C (+57.021464 Da). Peptides and proteins were
inferred from the spectrum identification results using PeptideShaker version 1.15.111. Peptide
Spectrum Matches (PSMs), peptides and proteins were validated at a 1.0% False Discovery Rate
(FDR) estimated using the decoy hit distribution. Post-translational modification localizations
were scored using the D-score and the phosphoRS score with a threshold of 95.0 as implemented
in the compomics-utilities package.
Calculation of Turnover Rates
Identification files and the MS-only mass spectrometry data were analyzed with the
DeuteRater software package12, which provided the protein turnover rates used for later analyses.
The resulting kinetic data was filtered to remove data with extreme outliers or other issues: First,
rates that were greater than 1 or less than 0.03 were eliminated from further analysis, as these
rates represented extrapolations outside of the range of rates that could be calculated confidently
with the time points used in the experiment. Since the kinetic proteomics data come from curve
fits of relevant measurements, all curves with a Pearson’s R2 less than 0.5, or with a covariance
(standard deviation/rate value) of greater than 0.2 were also removed from further analysis (the
standard deviation was divided by the turnover rate for normalization).
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Quantitative Proteomic Methods
Quantitative Mass Spectrometry Sample Preparation
A mouse liver labeled according to a Stable Isotope Labeling by Amino Acids in
Mammals (SILAM) protocol (Lys6:13C, Cambridge Isotopes) was purchased and homogenized
as described in the “Mass Spectrometry Sample Preparation” section above. For each sample, 50
µg of protein from the SILAM homogenate was combined with 50 µg protein from the sample
homogenate (with the exception of the diet A samples; since these underwent HPLC
fractionation, 150 ug was used instead of 50 ug). Three biological replicates from each dietary
group were prepared. Since isotopic shifts caused by D2O labeling creates difficulties in peptide
identification, only 0-day and 1-day time point animals (measured from the date of
intraperitoneal injection of D2O) were used for this experiment. The mixtures of SILAM and
sample homogenates were otherwise prepared identically to those described within the “Kinetic
Proteomic Methods” section.
Mass Spectrometry Analysis
Samples were re-suspended to 1 µg/µL concentration in 0.1% formic acid. Samples were
analyzed on a Thermo Lumos Tribrid instrument paired with a Thermo Easy-nLC 1200 HPLC.
Solvent A was 0.1% formic acid, 100% water; Solvent B was 0.1% formic acid, 80%
acetonitrile, 20% water (all solvents were LC-MS grade). Gradient was as follows: 0-45 minutes
was 5-45% Buffer B, 45-50 minutes 45-100% Buffer B, 50-60 minutes 100% Buffer B. The MS
scans were collected at 60,000 Resolution, with 20 MSMS scans between MS scans. MSMS
fragmentation was done with a 1.6 m/z isolation window, and CID fragmentation with 28%
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fragmentation energy. Fragment ions were measured in the Linear Ion Trap with the “Normal”
resolution setting.
Data Analysis
SILAM data was analyzed using the MaxQuant software package13 to quantify peptides
and proteins. All data was analyzed at the same time, with each dietary group analyzed as a
single experimental group. Constant modifications were carbamidomethylation for cysteine;
variable modifications allowed were oxidation of methionine and acetylation of the N-terminus.
The identification database was the same as that used for the kinetic analysis. Lys6 was added as
a heavy label; all other settings left at default. Unlabeled divided by labeled signal intensities
were determined and used to determine amounts of peptide in the sample relative to the SILAM
standard. The relative peptide abundances were then compared between samples.
Transcriptomics Methods
RNA-Seq
Following the manufacturer’s protocol, we used the Direct-zol RNA MiniPrep Plus kit
from Zymo Research to extract RNA from the liver tissue of all animals in this study. Briefly,
10-20 mg of frozen liver tissue from each mouse was processed using a Trizol extraction, and the
resulting RNA frozen at -80°C. Since we wished to identify changes in the transcriptome that
resulted only from dietary differences, RNA from three different mice in the same dietary cohort
sacrificed at different time points were pooled to form a single sample for RNA-Seq, thus
masking any differences resulting from temporal variations. Total RNA was extracted from
three pools per dietary cohort (4g of total RNA in 50 L of RNase-free water). Each pool was
submitted as a single sample to the BYU Sequencing Center. The BYU Sequencing Center
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constructed cDNA libraries after a poly-A pull-down to enrich for mRNA, and then sequenced
the libraries using an Illumina HiSeq 2500 sequencing platform. RNA-Seq gene count data were
analyzed in R14 using the DESeq215 package (see Appendices) in Bioconductor 3.3 from
Bioconductor.org15, downloaded on October 20, 2016.
RNA Motif Analysis
RNA motif analysis was performed using the HOMER motif analysis tool16 to detect any
translational preference due to RNA sequence motifs in the mRNA. Output from HOMER was
processed using in-house R scripts14.
DNA Turnover Rate Analysis
Since DNA turnover rate serves as a useful proxy for cellular division rate, we measured
the DNA turnover rates for all dietary cohorts by GC-MS using a previously published method6.
Briefly, DNA was extracted from 30-90 mg of frozen liver samples using the DNeasy kit
(Qiagen, Valencia, CA), and hydrolyzed to deoxyribonucleosides overnight at 37°C using S1
nuclease and potato acid phosphatase. The hydrolysates were reacted with pentafluorobenzyl
hydroxylamine and acetic acid, and then acetylated with acetic anhydride and 1methylimidazole. Dichloromethane extracts were dried, resuspended in ethyl acetate, and
analyzed via GC/MS on an Agilent DB-17 column with negative chemical ionization, using
helium as a carrier gas and CH4 as the reagent gas. The fractional molar isotope abundances at
m/z 435 (M0 mass isotopomer) and 436 (M1) of the pentafluorobenzyl triacetyl derivative of
purine dR were quantified using ChemStation software. Excess fractional enrichment of D2O
was calculated relative to an unlabeled pentafluorobenzyl triacetyl purine derivative, and fraction
new DNA was determined for each sample by comparing excess fractional enrichment to the
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calculated theoretical maximum. GraphPad Prism was used to perform least-squares fits to firstorder rate curves on plots of fraction new DNA versus time point. Standard deviation and
confidence intervals were calculated based on results from two biological replicates (each
measured three times) per time point. DNA turnover rates were analyzed and displayed using R
scripts14.
Multi-omics Data Analysis
Calculation of Ksynth and Kdeg Values
The model shown in Figure 1 suggests that the change in protein concentrations in cells
can be simplified as a balance between synthesis rate (which increases protein concentration),
and degradation and dilution (cell division) rates (which decrease protein concentration).
Equation 1 formalizes this relationship:
Equation 1:
𝑑𝑑[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃]
= 𝑘𝑘𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 [𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚] − 𝑘𝑘𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] − 𝑘𝑘𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑

Although protein concentration changes can be measured, separate measurements of in vivo
protein synthesis and protein degradation rates are not currently possible. By measuring
individual protein turnover rates in the same tissues used for the change in concentration, it
becomes possible to determine individual synthesis and degradation rates for each of the
observed proteins. Canonically, turnover can be described as the average of synthesis and
degradation rates (Equation 2, below).
Equation 2:
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𝑃𝑃𝑃𝑃𝑃𝑃𝑡𝑡𝑒𝑒𝑒𝑒𝑒𝑒 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 (𝐷𝐷𝐷𝐷𝐷𝐷 −1 ) =

𝑘𝑘𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 [𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚] + 𝑘𝑘𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃]
2

If the cells in the biological sample are terminally differentiated, as they are in most tissues of
adult mammals, then the division rate can be assumed to be very close to zero, and dropped from
Equation 1. At homeostasis, the change in protein concentration over time should be minimal,
thus enabling us to set d[Protein]/dt equal to zero in Equation 1. Algebraic rearrangement then
enables us to solve for the k-synth and k-deg values for every protein as a combination of
turnover rates, and either protein concentration or mRNA concentration (which can be provided
using RNA-Seq experiments). These equations are shown below (Equations 3 and 4), and were
used in calculations of synthesis and degradation rate constants for this study.
Equation 3:

𝑘𝑘𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 =

Equation 4:

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇(𝑑𝑑𝑑𝑑𝑦𝑦 −1 )
[𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚]

𝑘𝑘𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 =

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇(𝑑𝑑𝑑𝑑𝑦𝑦 −1 )
[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃]

Global Versus Selective Regulation Determination
Linear regression analyses were performed on turnover rate (Figure 4), protein
concentration (Figure 4), and RNA concentration (Figure 5). The global regression constants
were used to calculate expected values for each protein observed in the low protein dietaryrestricted (LP-DR) and high protein dietary-restricted (HP-DR) cohorts relative to the “control”
diets: low protein ad-libitum (LP-AL) for LP-DR, and high protein ad-libitum (HP-AL) for HP59

DR. This was done to identify protein specific regulation versus global regulation of the entire
proteome during low protein and high protein dietary restriction. A paired t-test between
predicted and experimental values was then analyzed using R scripts14 (see Appendices) for each
individual protein in LP-DR vs. LP-AL and HP-DR vs. HP-AL for turnover rate, quantitative
MS, and RNA-Seq data sets, generating a list of p-values for each analysis. To reduce false
positives, a q-value test was run in R using the qvalue package17 (see Appendices) for each
analysis, with an FDR level set to 0.01. Any proteins designated as not significantly different
were excluded from downstream analyses. A threshold of +/- 20% change was used to further
screen proteins that were significantly different from their predicted values; these were divided
into up- and down-regulated categories, respectively. Volcano plots generated using R (Version
1.1.463)14 were used to display the results of these tests (Figure 7).
Gene Ontology Analysis
Ontology groupings were determined using DAVID18,19. Proteins/gene lists were obtained from
the Global Versus Selective Regulation Determination analysis above. Ensembl IDs from RNASeq data were translated to UniProt accession numbers prior to ontology analysis. Each category
was input into DAVID18,19 against a background comprised of all protein ID’s in that particular
analysis (i. e. combined from up-regulated, down-regulated, and not significantly different
groups). Ontology groups with Benjamini-Hochberg coefficients less than or equal to 0.05 were
retained for analysis; all others were disregarded. Box plots generated using R (Version
1.1.463)14 were used to compare significant ontology groups (see Figure 8).
Ribosomal Subunit Analysis
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Turnover rate and quantitative MS data for all of the ribosomal proteins was extracted from the
larger data sets, and separated into two categories based on whether the ribosomal protein was
part of the large subunit (60S) of the ribosome or the small subunit (40S) of the ribosome. A
Mann-Whitney non-parametric rank order test20 was performed using Microsoft Excel (version
14.7.7) on turnover and quantitative MS data to detect whether the large subunit was turning
over significantly faster or if its concentration was significantly lower than the small subunit.
One-tailed p-values of 0.05 or smaller indicated significance.
Ribosomal Subunit Quantitative PCR (RT-qPCR)
cDNA samples were prepared according to the manufacturer’s protocol using the iScript cDNA
Synthesis Kit from Bio-Rad; sample RNA came from three biological replicates from each
dietary cohort (the RNA samples were randomly selected from previously prepared RNA used
for RNA-Seq; for preparation method, see RNA-Seq method section). The qPCR samples were
prepared in a 96-well qPCR plate using SYBR Green Master Mix from Bio-Rad. Primers were
ordered from Eurofins for the following targets: 28S rRNA (Forward primer: 5’GCGTTGGATTGTTCACCCAC-3’; Reverse primer: 5’-AGGGATAACTGGCTTGTGGC-3’),
18S rRNA (Forward primer: 5’-CTTAGAGGGACAAGTGGCG-3’; Reverse primer: 5’ACGCTGAGCCAGTCAGTGTA-3’), Vault RNA (Forward primer: 5’GCTGAGCGGTTACTTTGACA-3’; Reverse primer: 5’-GTCTCGAACCAAACACTCATG3’), and TATA (Forward primer: 5’-ACAGCCTTCCACCTTATGCT-3’; Reverse primer: 5’GATTGCTGTACTGAGGCTGC-3’). The qPCR reaction was run on a QuantStudio5 qPCR
machine (Applied Biosystems, ThermoScientific) using the standard settings for SYBR green
chemistry (QuantStudio Design&Analysis software, version 1.4.3); each biological replicate was
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run in duplicate. Data were analyzed using qbase+ software, version 3.2 (Biogazelle,
Zwijnaarde, Belgium – www.qbaseplus.com).
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Results
Differences in protein intake under dietary restriction resulted in measurably distinct
phenotypes.
Mouse weights were monitored throughout the dietary interventions in order to monitor
animal health and gather data on overall phenotypic effects of the various diets. Shown in Figure
3 below, there was no statistical difference between the two ad-libitum diets, suggesting that the
level of protein in the diets did not affect weight gain in at-will feeding. The dietary-restricted
cohort on the low-protein diet (LP-DR) initially showed a delay of 3 to 4 weeks before gaining
weight, but afterwards seemed to gain weight at the same rate as the ad-libitum (LP-AL and HPAL) cohorts. This suggests that the dietary restriction regimen, after an initial adjustment period
in which the metabolism of the organism shifts to accommodate lower nutrition, does not by
itself seriously impede normal growth in the mouse. In contrast, mice on HP-DR diets suffered
significant weight loss when they were subjected to dietary restriction. Over the course of two
weeks, the mice lost on average 20% of their body mass, and while they eventually began to gain
weight at a rate similar to the LP-DR mice, they never fully recovered all of their initial weight
loss. This suggests a substantial difference in the metabolism of LP-DR versus HP-DR animals
in this experiment, and how they react to dietary restriction. Such weight loss has been observed
in previous studies21, and provides verification that our dietary restriction interventions were
successful.
The mitochondrial respiration data that we collected immediately after sacrifice also
showed substantial differences between the low and high protein diets. Pair-wise t-tests were
conducted between the ad-libitum cohorts, the dietary-restricted cohorts, and between the
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dietary-restricted cohorts and their ad-libitum counterparts in low and high protein diets. While
the differences between LP-DR and LP-AL cohorts for D (ADP) and S (Succinate) testing were
only statistically suggestive (p < 0.10), the HP-DR was significantly lower than both HP-AL and
the LP-DR in all categories of the mitochondrial measurement, suggesting that mitochondria use
less oxygen in high protein dietary restriction. This does not translate to a decrease in efficiency,
however; the ratios of D/GM and S/GM for the high protein diets are comparable, if not higher
than the low protein diets (Figure 3). No statistically significant differences in efficiency were
detected between the diets, which suggests that higher protein levels do not impair mitochondrial
respiration; that the mitochondrial respiration in the high protein dietary restriction cohort is
lower in absolute terms may be due to modified expression of oxidative phosphorylation
pathway proteins (see “Individual functional ontologies may be regulated separately from the
global proteome change during dietary restriction” section below).
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Figure 3: Mouse phenotype data. Mouse weight and mitochondrial respiration data are shown for the four dietary
cohorts. The upper left panel shows the weekly mouse weight data over the 10 weeks of dietary treatment. Mouse
weights were normalized to starting weights before averaging. The ad-libitum cohorts, LP-AL and HP-AL, were
significantly different from the dietary restriction cohorts, LP-DR and HP-DR, which in turn were significantly
different from each other. The bottom two panels are bar graphs displaying the mitochondrial respiration data of the
dietary cohorts. “GM” is the mitochondria at rest with oxygen, “D” is the addition of ADP and oxygen to show the
function of the Electron Transport Chain (ETC) excluding complex 2, and “S” shows complex 2 added to the rest of
the ETC. The lower right panel displays the relative efficiency of the ADP effect (D/GM) and the Succinate effect
compared to mitochondrial leak (GM). All error bars represent 95% confidence intervals. Horizontal bars and
asterisks indicate significant differences.
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Dietary protein levels affect protein homeostasis globally in dietary restriction.
Using our kinetic proteomics method, we measured the protein turnover rates for over
1000 mouse liver proteins for all of the dietary intervention cohorts. We found that on average,
the turnover rates of the proteins slowed significantly in both LP-DR and HP-DR (Figure 4,
below, top panels), with HP-DR decreasing global protein turnover rates less than LP-DR. This
agrees well with previous studies in which dietary and calorie restriction have been shown to
decrease the overall rates of protein synthesis and degradation22. Generally, protein quantity
decreased for the ~1000 proteins measured in the LP-DR group. HP-DR showed almost no
change in cellular protein quantity (Figure 4, below, bottom panels). According to our model
(Figure 1), the combination of turnover rates and protein quantification enables us to describe
these global differences as the result of changes in either protein synthesis or degradation. In this
case, our data supports a fundamental difference in the global protein metabolism between the
dietary protein conditions: With low protein, protein synthesis appears to be slowed globally,
while high protein shows both decreased synthesis and degradation.
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Figure 4: Protein turnover rate and quantitation comparisons between dietary restriction and ad-libitum. In
the scatterplots above, each point represents the intersection of the turnover rates (upper two panels) or the
quantitation (lower two panels) between dietary restriction (y-axis) and ad-libitum (x-axis) cohorts for a single
protein. For each plot, the dotted line represents the identity line (y = x) with a slope of one, the dashed line
indicates the linear regression fit line (equation and R-squared values displayed; all slope p-values << 0.00001 – see
Table S1 in Appendices), and the error bars indicate 95% confidence intervals. Note that if the dashes and dots lie
along the same line, this indicates no average difference between dietary restriction and ad-libitum cohort
measurements.
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Dietary restriction alters the global proteome post-transcriptionally.
We used RNA-Seq to measure the change in mRNA concentration between our dietary
cohorts. The results show almost no change between ad-libitum and dietary restriction
interventions, regardless of whether the mice were on low protein or high protein diets (Figure
5). Given that the turnover rates and concentrations of the proteins changed so markedly under
dietary restriction, this lack of global perturbation in the transcriptome is remarkable. We
concluded from this that the regulatory changes induced by dietary restriction occurred posttranscriptionally.
One possibility for the post-transcriptional regulation is that RNA sequence motifs, such
as micro-RNA motifs and transcriptional activating factors that are known to regulate mRNA
longevity and translation23, may be influencing downstream protein translation rates and levels.
An analysis of the RNA-Seq data showed no correlation between known motifs and the levels of
protein expression downstream in our study (data not shown). This indicates that the posttranscriptional regulation under dietary restriction is unlikely to result from RNA sequence-based
regulation. Our global analysis of turnover, quantitation, and RNA-Seq data points toward
regulatory changes happening at protein translation, post-translational processing, or degradation
steps.
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Figure 5: Comparisons between dietary restriction and ad-libitum mRNA amounts. In the scatterplots above,
each point represents the intersection of the normalized log of the mRNA counts measured by RNA-Seq between
dietary restriction (y-axis) and ad-libitum (x-axis) cohorts for a single gene. For each plot, the dotted line represents
the identity line (y = x) with a slope of one, the dashed line indicates the linear regression fit line (equation and Rsquared values displayed; confidence interval statistics listed in Table S1 in Appendices), and the error bars indicate
95% confidence intervals. Note that if the dashes and dots lie along the same line, this indicates no average
difference between dietary restriction and ad-libitum cohort measurements.

69

Addition of dietary protein alters cellular division rates in dietary restriction.
Since protein concentration can be decreased through cellular division as well as
degradation and other processes, we used a GC-MS method to measure DNA turnover rates,
which is an accepted metric of cell division24. DNA normally replicates only once per cellular
division; thus, the turnover rate of DNA should be identical to the cellular division rate. Our
data showed that the cellular division rates were largely identical between cohorts, with the
exception of the high protein dietary restriction (HP-DR); the cellular division rates in this dietary
cohort were significantly decreased compared to low protein dietary restriction (LP-DR) and high
protein ad-libitum (HP-AL) (Figure 6). While at first glance this may seem to explain the
difference in average protein quantitation concentration (Figure 4, bottom panels) between LPDR and HP-DR, an examination of the scale of the turnover rates shows that the DNA turnover
rate is one to two orders of magnitude smaller than the protein turnover rates, and thus cannot
account for the difference alone. It seems more likely to us that the high protein levels interfere
with normal dietary restriction metabolic reprogramming, decreasing cellular health, which would
cause delays in cell proliferation.
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Figure 6: Cellular proliferation rates differed between dietary treatment groups. Average DNA turnover rates
are shown as fraction/day for DNA in LP-AL, LP-DR, HP-AL, and HP-DR cohorts. Error bars indicate 95%
confidence intervals. Asterisks and horizontal brackets indicate significant differences between high protein dietary
restriction (HP-DR) and high protein ad-libitum (HP-AL), as well as low protein dietary restriction (LP-DR).
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Individual functional ontologies may be regulated separately from the global proteome
change during dietary restriction.
The turnover and quantitation data indicated that the entire proteome was undergoing
global shifts in metabolism due to dietary restriction and protein intake levels. This was not
unexpected, and indeed was logical considering the broad phenotypic changes observed with
dietary restriction; however, the mechanisms causing this global shift in regulation are likely to
be masked by the overarching changes in the proteome. Nevertheless, we sought to investigate
those protein functional groups and pathways that may be involved in causing this global shift.
We reasoned that the regulation of these proteins may be perturbed differently from the overall
global regulation; therefore, proteins that were only shifted globally should be very similar in
relative turnover and quantitation changes, while the selectively regulated proteins should be
significantly different. To separate these regulation levels, we first calculated turnover,
quantitation, and gene count (RNA-Seq) values for the dietary restriction cohorts based on the
ad-libitum controls and the regression line values in Figure 4 and Figure 5. These predicted
values were then compared to the values measured experimentally, and the differences tested for
statistical significance, as detailed in the Methods. We conservatively allowed for a +/- 20%
noise level, and selected proteins that were significantly outside of this range for further analysis
(the volcano plots in Figure 7 illustrate this selection process).

72

Figure 7: Experimental versus predicted values for turnover rates, quant, RNA-Seq counts, k-synth, and kdeg. Q-values for the comparisons between experimental and predicted values for the various measurements are
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plotted on the y-axis, while the x-axis shows fractional change between the experimental and predicted values. The
blue lines indicate a Q-value of 0.05 on the phred scale, and the red lines indicate the cutoff of a +/- 20% difference.
Numbers of significant proteins are indicated; these numbers may or may not correlate with the displayed points on
the graph, as some of those displayed points were eliminated by the q-value test, but still included in the graphic.
Outliers past the ranges of the x-axis and y-axis are included in the numbers, but were not displayed in order to keep
the plot scales uniform. In each graph, the predicted values were calculated based on linear regression fits between
dietary-restricted and ad-libitum cohort values. The top row shows experimental versus predicted rate data for low
protein (LP) dietary restriction and high protein (HP) dietary restriction cohorts. Subsequent rows display the same
analysis applied to quantitative MS data, RNA-Seq data, k-synth values, and k-deg values.
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Among the differentially expressed proteins, three broad functional categories of
proteins emerged: mitochondrial, endoplasmic reticulum, and secreted. The k-synth and k-deg
values for these proteins are plotted in Figure 8, below. Key differences were revealed between
the high and low protein cohorts: Endoplasmic reticulum proteins were not significantly shifted
in LP-DR, but for HP-DR, their synthesis rate constants were increased and degradation rates
decreased relative to the global regulation. This may reflect the need for more protein processing
capacity under high protein conditions, and would agree with our previous hypothesis that
mTOR signaling is elevating translation in response to the high protein diet. Synthesis rate
constants for secreted proteins in both LP-DR and HP-DR were elevated, while degradation rate
constants remained mostly unchanged relative to global regulation. We hypothesize that
regardless of the changes in the cellular metabolism, the liver cells need to maintain their
secretory functions25 to maintain overall tissue and organismal homeostasis.
Mitochondrial proteins displayed an increase in synthesis rate constants in LP-DR, while
their degradation rate constants remained unchanged relative to global regulation. This indicated
that the mitochondrial proteins were under selective synthesis control, and that maintaining
higher levels relative to other cellular proteins in dietary restriction confers benefits for cellular
health, presumably by keeping energy flux at healthy levels. In contrast, HP-DR caused a
decrease in both synthesis and degradation rate constants of mitochondrial proteins. Decreased
degradation of mitochondrial proteins through mitophagy, the primary degradation pathway for
mitochondria26, would be predicted to manifest as decreased turnover and increased
concentration, and we see this in our data. We reason that the corresponding reduction in
synthesis may thus be necessary in order to maintain homeostasis. Such a slowdown in the
metabolism of mitochondrial proteins is interesting, given the attention that oxidative damage
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caused by ROS (reactive oxygen species) created in the mitochondria has received in previous
studies of dietary restriction27. ROS are thought to accelerate aging through the induction of
oxidative damage; one dietary restriction hypothesis is that the health and longevity benefits
result from the reduction of this oxidative stress27. If mitochondria lag in turning over, it is likely
that their proteins will become more damaged and less functional over time, leading to
deficiencies in mitochondrial function, which may produce more ROS and subsequent damage to
the cell. This may provide an explanation for the attenuation of dietary restriction benefits by
high dietary protein intake seen in previous studies4.
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Figure 8: K-synth and k-deg comparisons of unique proteins from significant ontology groups. Combined dot
and box plots are shown of the k-synth and k-deg constants for the three significant ontology groups determined
through the online ontology analysis tool DAVID18,19: endoplasmic reticulum, mitochondria, and secreted proteins
were all significantly shifted from the global proteome regulation of dietary restriction. High protein (HP) is
indicated in dark grey, while low protein (LP) is indicated in light grey. Each dot represents the k-synth or k-deg
value for a unique protein. The interquartile range is indicated by the reduced width towards the median; nonoverlap of interquartile ranges is indicative of a significant difference. Here, the emphasis is on direction of change
from expected values. The dotted red line indicates the predicted (global) values for high protein, and the dashed
blue line indicates the predicted (global) level for low protein dietary cohorts. Only unique protein id’s matched
between dietary cohorts in each category were kept for this analysis; protein id’s that were shared between ontology
categories were eliminated from these plots.
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Ribosomal subunits display differential degradation rates under dietary restriction.
Adjustments in energy flux through manipulation of mitochondrial metabolism may
provide part of the answer for dietary restriction benefits, but this does not speak directly to the
cause of the globally decreased protein quantity and turnover observed in our data. To this end,
we began to examine other possible nodes of regulation; the ribosome immediately attracted our
attention in its role as a central control locus for protein synthesis. In previous work, we reported
that certain ribosomal proteins had faster turnover rates than the ribosome as a whole, and
hypothesized that some proteins were being replaced piecemeal as part of a ribosomal
maintenance mechanism28. The mice in that study were fed high-protein ad-libitum or highprotein dietary restriction diets. Since a low-protein dietary restriction diet is reportedly healthier
than a high protein diet4, and increased ribosomal maintenance should contribute to improved
proteome quality, we reasoned that we should see magnified differences in the turnover rates and
quantities of these “fast turnover” ribosomal proteins compared to the high protein diet.
An examination of the ribosomal proteins with the fastest turnover rates showed little
overlap between low and high protein dietary cohorts. Moreover, the ribosomal protein turnover
rates appeared to be changing less in LP-DR compared to HP-DR. While this did not directly
refute the partial replacement hypothesis we previously proposed, the data appeared to imply that
something else was occurring. A cursory examination of the ribosomal proteins turning over
fastest in LP-DR and HP-DR, while not overlapping, seemed to show a bias towards large
subunit ribosomal proteins. We applied a Mann-Whitney rank-order test (see Methods) to test
whether the large (60S) and small (40S) ribosomal subunits were turning over at different rates.
The results (displayed in Figure 9) confirmed that the large subunit proteins were turning over
significantly faster than the small subunit proteins in both LP-DR and HP-DR, as well as HP-AL
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diets. When we applied the same statistical test to the quantitative MS data, the large subunit
proteins were seen to be lower in concentration than the small subunit proteins in LP-AL as well
as LP-DR, but in high protein diets, only HP-AL had a significant reduction in large subunit
proteins compared to small subunit proteins. This implies that under low protein dietary
conditions, it is normal for non-stoichiometric ratios of ribosomal subunits to be maintained in
the cell, but under dietary restriction this ratio is skewed more heavily in favor of the small
subunit as the large subunit undergoes increased degradation. Under high protein conditions,
this dietary restriction reprogramming appears to be mitigated by a competing signal that brings
the degradation of the large and small subunits more in line with each other.
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Figure 9: Ribosomal subunit analysis. Turnover rates (panel A) and quantitation (panel B) for the ribosomal
proteins observed in each of the dietary cohorts (data listed in Table 1 below). For each of the dietary cohorts
(indicated on the x-axis), the ribosomal proteins were separated by whether they were part of the large subunit (60S
(L)) or the small subunit (40S (S)) of the ribosome, and then plotted separately: large subunit protein data is shown
in light grey, and small subunit protein data is shown in dark grey. The interquartile range is indicated by the
reduced width towards the median, and significant differences (determined by one-tailed t-test) are indicated by
asterisks and horizontal lines.
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Table 1: Ribosomal subunit protein concentration and turnover rate data. Data for the ribosomal subunit
analysis in Figure 9 is shown below. Quant MS (ratio relative to internal standard) and turnover rate (fraction per
day) data are listed for 73 ribosomal proteins. All data except missing values were plotted (“NA” indicates missing
data). “+/- 95% C.I.” indicates the computed 95% confidence interval value for the associated value.
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Ribosomal RNA quantities do not correlate with ribosomal proteins
The differences observed in ribosomal protein metabolism could be due to changes in
degradation of the ribosome as a unit or the individual proteins. Therefore, in order to test
whether the large and small ribosomal subunits were being differentially degraded in response to
dietary restriction, we performed RT-qPCR on two ribosomal RNA’s (rRNA’s): the 16S rRNA
(small subunit), and the 28S rRNA (large subunit). The results are shown in Figure 10 below.
Based on the ribosomal protein quantitation data (Figure 9), we expected that the high protein
cohorts should show comparable values for the large and small subunit rRNA’s (although the
differences were statistically significant, the large range of the data suggests that perhaps they
are not very different), and the qPCR bears this out. However, we were very surprised to see that
the low protein cohorts showed the opposite trend to the protein quantitation: the large subunit
rRNA was in greater quantity than the small subunit rRNA, ad libitum relative to dietary
restriction. This result directly contradicts the hypothesis that differential degradation of
ribosomal subunits may be responsible for slowing translation in response to dietary restriction.
However, this data is only preliminary, and the RT-qPCR experiment needs to be repeated for
verification. Possible implications of these RT-qPCR data are presented in the Discussion.
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Figure 10: Ribosomal rRNA quantitation by RT-qPCR. The 16S and 28S rRNA molecules in each dietary
cohort were quantified and compared by RT-qPCR. The left panel shows the normalized expression levels in
arbitrary units. The right panel shows the rRNA ratio of dietary restriction (DR) to ad libitum (AL) in both high
protein (HP) and low protein (LP) diets: 16S rRNA DR/AL and 28S rRNA DR/AL. Error bars in both panels
indicate 95% confidence intervals. In the ratio comparisons, only the low protein 28S rRNA values were
significantly different between AL and DR.
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Discussion
Dietary restriction has long been known to extend lifespan and healthspan for a variety of
model organisms. The mechanism behind dietary restriction remains debated, but one
observation that has consistently emerged from dietary restriction studies is the slowdown of
protein synthesis compared to an ad-libitum diet22a,29,30. Logically, this provides the cell with
several benefits: Decreased protein synthesis lowers the burden for raw materials and energy in
the cell, an advantage when adjusting to the lower nutrient conditions of DR. Multiple studies
have reported that lower translation rates enable higher quality proteins to be made through
improved translational fidelity31, increased co-translational folding time, improved chaperone to
nascent protein ratios, and lowered burdens on the protein synthesis quality-control machinery
such as the ribosomal quality-control complex32. We have previously proposed that ribosomes
undergo maintenance to swap out damaged or malfunctioning proteins28; decreasing the protein
synthesis burden would enable more ribosomes to be available for maintenance, increasing the
quality of the available ribosome pool, which would presumably increase the quality of proteins
produced during translation. As an additional consequence, the burden on degradation
machinery would also decrease, as overall protein quality improved, enabling selective targeting
of dysfunctional proteins for degradation that would otherwise form aggregates. The formation
of protein aggregates within cells is a characteristic of many age-related diseases33. Thus,
decreasing the protein synthesis burden on the cell is an attractive candidate for a global
mechanism behind the health benefits of dietary restriction.
There are several possible mechanisms whereby global protein synthesis could be
slowed. Previous studies have determined that dietary restriction triggers nutrient sensors in the
cell that alter protein synthesis34. Gcn2 is a nutritional sensor that activates in response to an
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increase in uncharged tRNAs in the cytosol, a change that occurs during nutritional stress34. In
response, Gcn2 rapidly inhibits the formation of the ternary translation initiation complex34.
mTOR is another well-characterized nutrient sensor that increases protein translation in response
to amino acid signaling; under dietary restriction, mTOR is less active, and translation is
slowed35. Other pathways, such as the insulin/IGF-1 and MAPK pathways, also have direct
effects on translational levels in response to nutritional signals36.
Dietary restriction can also be viewed as the application of a cellular stress, to which the
cell may respond by formation of stress granules37. Stress granules are non-membrane bound
aggregations of mRNA and associated proteins that represent incomplete initiation complexes38.
Though the literature on stress granule formation in dietary restriction is sparse, there is evidence
of stress granule formation under similar conditions of more specific nutrient depletion39,40. This
formation of stress granules may represent an additional mechanism for altering the rate of
protein synthesis in cells under dietary restriction. Interestingly, a recent proteomics study of
stress granules reported that while small ribosomal subunit proteins can be found within stress
granules, large ribosomal subunit proteins are conspicuously absent41.
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Figure 11: A model for decreasing global translation in dietary restriction. Dietary restriction (DR) increases
the formation of stress granules, which segregate mRNA associated with translation initiation factors and small
ribosomal subunits (40S) away from the general cytosol, inhibiting protein translation and degradation of the small
ribosomal subunit proteins.
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Given these findings, plus the data in the current study, we propose here a model in
which the formation of stress granules during dietary restriction represents an additional
mechanism for slowing protein translation through the sequestration of mRNA and associated
proteins, including the small (40S) ribosomal subunit (Figure 10). In this model, the stress
granules inhibit translation directly by preventing the association of the large ribosomal subunit
with the translation initiation complex. Protein synthesis is also indirectly hindered since the
sequestration of the small (40S) ribosomal subunit prevents its degradation through cytosolic
ribophagy, causing the ratio of 60S to 40S ribosomal subunits to fall below a more efficient nearstoichiometric match.
Our data contain several lines of support for such a phenomenon. The kinetic proteomics
(Figure 4), combined with the quantitative proteomics results (Figure 4), indicated that dietary
restriction was affecting primarily protein synthesis; however, the lack of significant changes in
our transcriptomic data (Figure 5) pointed to a post-transcriptional regulatory mechanism.
Mitochondria, endoplasmic reticulum, and secreted protein groups escaped this global synthetic
slowdown (Figure 8); there is some literature support that sequestration into stress granules can
be sequence-specific42,43, although this is still debated.
The strongest support for this model comes from the turnover and quantitative MS data
for the ribosomal proteins (Figure 9). When taken together, the increase in turnover rate and
drop in quantity for the large (60S) ribosomal subunit relative to the small (40S) ribosomal
subunit points to preferential degradation of the 60S subunit versus the 40S subunit. Although
we believe that the simplest method is through sequestration of the 40S ribosomal subunit into
stress granules where it is protected from cytosolic degradation relative to the 60S subunit, one
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can envision a number of alternative ways the cell could increase the degradation of the large
ribosomal subunit relative to the small subunit. For example, ribophagy could be targeted
towards the large subunit through post-translational modification of the large subunit ribosomal
proteins, or the large subunit as a whole. There could also be a more passive bias in ribophagy
(possibly based on steric hindrance) towards degradation of ribosomal subunits that are
unassociated with mRNA: given that the small ribosomal subunits are a vital component of the
ternary complex that initiates translation, and the large subunit is the last component to be added
before translation begins, it is logical that the small subunit would spend more time associated
with mRNA. This provides one possible explanation for the difference in degradation rates that
we see in the high protein ad libitum (HP-AL) cohort: increased mTOR signaling in response to
higher dietary protein would lead to increased translation, thus increasing the number of small
subunits associated with mRNA and decreasing the pool of free small ribosomal subunits.
The increased level of dietary protein itself may cause translational stress to the cell, as
mTOR increases the level of protein translation past a healthy level under dietary restriction.
mTOR is a major node of protein synthesis regulation that responds to changes in amino acid
availability, especially leucine44; increased amino acid concentrations in the cell have been
shown to upregulate mTOR signaling, stimulating the translation of proteins35. We hypothesize
that the additional dietary protein in dietary restriction results in activation of mTOR, increasing
protein synthesis despite the dietary restriction conditions, resulting in competing nutritional
signals that result in the protein concentration within the cell remaining more or less constant
(Figure 4). Evidence of increased mTOR activity can also be seen in the selective decrease in
degradation of mitochondria under high protein dietary restriction (Figure 8); mTOR is also
known to be a control node for the regulation of cellular autophagy22b. The increased protein

88

translation burden caused by increased mTOR activity can logically be expected to cause a strain
on cellular resources under lowered nutrient conditions, and may lead to decreased cellular
fitness and attenuation of dietary restriction health benefits in the long term, as seen in other
studies4. This extra level of stress would thus be expected to increase the number of stress
granules, magnifying the sequestration of 40S ribosomal subunits.
To test this hypothesis, we performed an RT-qPCR experiment to measure the expression
levels of 16S and 28S rRNA. These are constitutive components of the small and large
ribosomal subunits, respectively, and the quantities of each should correlate tightly with the
amounts of the small and large subunits themselves. If the sequestration model is correct, we
expect that the concentration of 28S rRNA relative to 16S rRNA will decrease under dietary
restriction, since it is only the small ribosomal subunit that is sequestered in stress granules. Our
qPCR results showed that while the high protein dietary cohorts had rRNA levels that
approximately correlated with the ribosomal protein concentrations (i.e. there was little
difference between AL and DR diets), the low protein cohorts instead displayed increased 28S
rRNA relative to 16S rRNA during dietary restriction. This is a preliminary experiment, and
needs to be repeated for verification; for example, simple sample confusion may have resulted in
erroneous data. Other possibilities include biases in the reverse transcription of 28S rRNA
versus 16S rRNA (ribosomal RNA is known to be heavily modified45 and this may be
problematic), or primer bias in the qPCR could have resulted in skewed amplification of the
rRNA. Temporal biases in ribosomal levels in the cell due to diurnal cycling46 could also be a
factor. However, if the data are true, they would either directly disprove the proposed model, or
indicate other possible scenarios, such as a disconnect between ribosomal protein and ribosomal
RNA metabolisms in response to dietary signaling. Ribosomal biogenesis is tightly controlled
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and coordinated in the cell47, so this possibility would necessitate a rigorous set of research
experiments to produce supporting evidence.
Given the large energy and material investment the cell makes in creating the ribosomal
subunits, it seems counter-intuitive that a reduction in the 60S:40S subunit ratio by increased
degradation of the large subunit proteins would lead to a healthier, more efficient proteostatic
equilibrium. However, this may enable the overall quality of the large ribosomal subunit pool to
increase, which may increase the proofreading accuracy of the ribosome. Future experiments
specifically targeting the ribosomal proteins to assess post-translational modifications and
damage due to oxidation would be useful. Other future experiments determining individual
rRNA turnover rates would be used to support the 40S and 60S subunit protein turnover rates;
the ribosomal proteins cover a spectrum of turnover rates, and the subunit turnover rates as a
whole are inferred. Calculation of mRNA turnover rates would shed light on whether mRNA is
being sequestered and presumably protected from degradation under dietary restriction (although
reported exchanges of mRNA in stress granules with p bodies and the cytosol48 may complicate
the picture). (We did have data on the turnover rates for total RNA, which were suggestive of
higher turnover for all species of RNA under dietary restriction, but without a reliable way to
distinguish the turnover rates of the various species of RNA from each other, more definitive
conclusions were not possible.) More comprehensive proteomics studies of stress granules
including kinetic measurements would be illuminating, as well as a measurement of the number
and size of stress granules in dietary restriction through staining and microscopy.
Taken together, these future directions would either confirm or disprove the slowdown of
protein synthesis through sequestration of ribosomal subunits into stress granules. Interestingly,
the model itself presents a “which came first: the chicken or the egg?” kind of question, one
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which is not answerable at present: Does dietary restriction trigger stress granule formation to
alter protein expression in order to confer survival benefits, with the ribosomal subunit turnover
differential as a side effect? Or is the goal to reduce long-term translation rates by altering the
60S:40S ratio through degradation, with sequestration the mechanism for achieving this goal?
Although it may seem rather academic, as researchers pursue dietary restriction mimetics for
increasing human longevity and health, this may become important in deciding which cellular
proteins to target for intervention.
In summary, we present a methodology that needs only four measurements to monitor
proteostasis regulation at the systems scale. We applied this approach to short-term dietary
restriction in mice under low and high dietary protein conditions. The data from our experiments
allowed us to recapitulate many of the phenomena that have previously been observed in dietary
restriction, albeit in combination here rather than in isolation. Moreover, we propose that under
dietary restriction, the cell decreases global protein synthesis through the sequestration of the
small ribosomal subunits into stress granules. This global slowdown in translational burden
lowers energy and raw material demands on the cell, and improves protein folding and quality
control49. Ultimately, these improvements in proteome metabolism and maintenance lead to
improvements in cellular health and longevity observed under dietary restriction.
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CHAPTER 3
“Exploratory Investigation of AGE-Mediated Attenuation of Calorie Restriction Benefits in Mice
Using a Combined Omics Method”
This chapter represents the focus of my original research aim, which was to investigate
the effect of AGEs (advanced glycation end-products) on calorie restriction. Previous studies
had shown that these protein modifications attenuated and even canceled the life-extending
benefits of calorie restriction; however, the mechanism was unknown. This presented a novel
opportunity for application of our kinetic proteomic method, along with other omics
methodology, to produce a comprehensive mapping of the AGE effect on cellular metabolism.
Unfortunately, the data were mostly negative: we did not see a profound change in calorie
restriction caused by dietary AGEs. Because of logistical reasons, this study could not be easily
repeated and refined, so the analysis presented in this chapter represents more of a work in
progress, wherein the data is best viewed as preliminary for a more rigorous and ambitious future
experiment. The complete data analysis was useful and necessary, however, to confirm the lack
of a detectable profound AGE effect under these experimental conditions, hence its inclusion in
this dissertation. Combined with the results presented in Chapter 2, this study provides the basis
for experimental modification, as well as baseline data, for continuing the investigation into the
negative consequences of AGE consumption during calorie restriction.
Unlike Chapter 2 and Chapter 4, in which I benefitted greatly from close collaboration
with coauthors, the experiments and data analysis were primarily executed by myself. By itself,
the results of this study do not merit publication as a scientific paper. It is my hope that this
work will be continued by a future student who will be able to use the data to gain fundamental
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insight into how to mitigate the potential damage that AGE-heavy Western diets are causing to
an aging population.
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Title
“Exploratory Investigation of AGE-Mediated Attenuation of Calorie Restriction Benefits in Mice
Using a Combined Omics Method”

Abstract
Calorie restriction (CR) is a time-tested method for improving the health and lifespan of
laboratory animals. Studies show, however, that the addition of protein modifications termed
“advanced glycation end-products” (AGEs) to the diet of calorie-restricted animals can lead to
the attenuation of these health benefits and a shortening of lifespan. As these compounds are
widely prevalent in modern Western diets, this has significant implications for human health.
We hypothesized that these AGEs constituted an abnormal dietary signal that disrupted protein
homeostasis and decreased the quality of the cellular proteome, and used a multi-omic approach
comprised of kinetic proteomics, quantitative proteomics, and transcriptomics to investigate the
liver proteomes of C57/BL6 male mice on calorie restriction with additional AGEs. Our results
showed that the measurable proteomes of mice on a calorie-restricted diet supplemented with a
small amount of AGE are not significantly different from isocaloric control mice with either a
small amount of additional dietary protein, or no additional protein at all. This suggests either
that the effects of AGEs in the diet were too subtle to detect, and were overwhelmed by a
dominant CR phenotype, or the experimental doses were too small to cause a significant
difference between the dietary cohorts in the liver tissue. Additional experimentation will be
necessary to distinguish between these possibilities.
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Introduction
Human lifespans have increased markedly in the past century, accompanied by dramatic
increases in age-related diseases such as cancer1. Cardiovascular disease, kidney disease, type II
diabetes, and neurodegenerative diseases such as Alzheimer’s are increasingly common2, and
place a heavy burden upon aging populations; developing more effective treatments and
therapies for these diseases is therefore imperative.
Calorie restriction has attracted a great deal of attention for its ability to improve both the
health and lifespan of model organisms. A calorie-restricted diet involves a significant reduction
in total calories (up to 60%) without malnutrition, and although not currently considered
practical for widespread human application, modifications such as short-term calorie restriction
and intermittent fasting hold promise3. From a research standpoint, calorie restriction provides a
model for healthy aging that can be studied not only to learn more about the etiology of aging,
but also to discover targets for pharmacological interventions that would not only forestall
deleterious aging processes, but prevent age-related diseases by treating the root cause: agerelated physiological decline.
The importance of diet in the aging process can also be seen in the discovery that dietary
AGEs (advanced glycation end-products) can attenuate and even cancel the benefits of a calorierestricted diet in laboratory animals4. Advanced glycation end-products (AGEs) result from the
irreversible non-enzymatic reaction of reductive sugars with peptides, proteins, and lipids, and
can be formed both in vivo and ex vivo5. These AGEs can be found in high amounts in the
typical Western diet6, which is abundant in sugars, fats, and animal protein. Perhaps not
coincidentally, first world countries are currently suffering from epidemic levels of insulin
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resistance, diabetes, and obesity7, as well as a rise in other traditionally age-related diseases
among younger people8. Could AGEs be accelerating deleterious aging processes, thereby
increasing these disease rates?
The ingestion of AGEs has been shown to increase systemic oxidative stress and
inflammation levels, which have been tied to increased susceptibility to insulin resistance,
diabetes, cardiovascular disease, and kidney disease4. Inflammation also plays a large role in
cancer: chronic inflammation can drive tumorigenesis, suppress anti-tumor immune responses,
stimulate angiogenesis, and advance metastasis9. Although the mechanism for AGE-mediated
cancellation of calorie restriction benefits is incompletely understood, it is likely to be related to
increased inflammation, a hallmark of aging10.
The purpose of the current study was to explore these effects on the proteome of calorierestricted mice. Our hypothesis is that calorie restriction functions by improving protein
homeostasis (proteostasis), with ripple effects extending to tissue, organ, and overall health.
AGEs, by extension, are predicted to disrupt the beneficial reprogramming of proteome
regulation, mitigating the effects of calorie restriction. The specifics of this disruption, and the
magnitude of the changes in the proteome, were the focus of this study.
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Methods
Animal Handling:
Mouse housing, genotype, and diet
All animal procedure protocols were approved by the Institutional Animal Care and Use
Committee (IACUC) of Brigham Young University. Housing for mice was provided in a
pathogen-free facility for the duration of the experiment. 10-week old C57/BL6 male mice were
purchased from Charles River Laboratory, and fed ad-libitum for one week after arrival to
acclimate to the facility. Mice were then randomly divided into dietary cohort groups of 9 mice
each: ad-libitum (AL), calorie-restricted (CR), calorie-restricted with additional protein (CR
PROT), and calorie-restricted with additional AGE protein (CR AGE); the mice were housed
individually to ensure equal access to food. All animals were fed NIH31 chow, with the CR
animals receiving a variant fortified with additional nutrients. AL animals had constant access to
food, and CR animals were fed daily a pellet of 3g ± .1g in size (65% of expected AL
consumption). Additional protein and AGEs were added to the E and E2 diets by pipetting a
small amount (4.2 mg in PBS buffer) of either BSA (bovine serum albumin) or AGE-modified
BSA directly onto the pellet rations and letting them dry before feeding (the additional calories
were judged to be minimal, and the diets judged to be isocaloric to the normal CR diet). Mice
were weighed weekly during one of the daily feedings of CR animals to monitor health and
weight loss.
Movement Data Collection
The activity of the mice was measured using an in-house constructed motion sensor
apparatus. This apparatus consisted of four low-power infrared light emitters and four infrared
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sensors connected to a computer equipped with the LabVIEW program11; with the emitters lined
up on the outside of a mouse cage on one side, and the sensors positioned opposite of the
emitters on the outside of the other side of the mouse cage, interruptions in the infrared beams
could be detected whenever the mouse inside the cage crossed the beams. The number of beam
crosses was recorded over a twenty-four period for each mouse measured in order to minimize
variations due to nocturnal/diurnal activity level differences. The total number of beam crosses
was divided by the total time of the measurement in order to eliminate differences between
measurements due to minor time differences, as well as to provide an average movement rate.
Each mouse was measured at least twice, and any irregularities, such as apparatus or computer
malfunction, that occurred during a measurement, no matter how minor, eliminated that
measurement from the downstream analysis.
Metabolic Labeling
At 10 weeks, (except for the 0-day time points, one per dietary cohort) the mice were
given an intraperitoneal bolus injection of sterile D2O saline at 35 µL/g body weight. This
injection brought the mice up to 5% Molar Percent Excess (MPE) deuterium as previously
described12. Mice were then provided drinking water containing 8% MPE to maintain the 5%
MPE in the animals’ body water.
Euthanasia and Sample Collection
Two animals from each diet were sacrificed at 1 day, 3 days, 9 days and 27 days after
bolus injection, with one animal from each group sacrificed without receiving a bolus injection
or any other D2O labeling. Mice were anesthetized with CO2 and then euthanized by cardiac
puncture. Mice were then immediately dissected and all tissues except for blood were flash
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frozen on solid CO2 and then stored at -80°C. Blood was stored on ice until it could be
centrifuged at 800 x g for 10 minutes at 4°C. The centrifugation separated serum and red blood
cells, which were stored in separate containers at -80°C.
Mitochondrial Respiration
Fresh liver tissue was quickly removed from exsanguinated mice and immediately placed
in ice-cold mitochondrial respiration buffer (MiR05: 0.5 mM EGTA, 10 mM KH2PO4, 3
mM MgCl2-6 H2O, 60 mM K-lactobionate, 20 mM HEPES, 110 mM Sucrose, 1 mg/ml fatty acid
free BSA, pH 7.1) and trimmed of connective tissue. Tissue was gently separated and
homogenized under a surgical scope (Olympus, ST) to particles of approximately 1 mg.
Homogenate was then transferred to a tube with chilled MiR05 and 50 μg/ml saponin and rocked
at 4 °C for 30 min, then washed in MiR05 at 4 °C for at least 15 min before use. High-resolution
O2 consumption was determined at 37 °C using the Oroboros O2K Oxygraph. Before addition of
sample into respiration chambers, a baseline oxygen consumption rate was determined. After
addition of sample, the chambers were hyperoxygenated to ∼350 nmol/ml., and respiration was

determined according to the manufacturer’s protocol. Lastly, residual oxygen consumption was
measured by adding antimycin A (2.5 μM) to block complex III action, effectively stopping any
electron flow and providing a baseline respiration rate.
Kinetic Proteomic Methods
Measurement of MPE
Aliquots of serum were distilled in 2.0 mL screw cap tubes overnight in a 90°C sand
bath, and the distillates collected. The distillate was diluted 1:300 in ddH2O, and MPE of
deuterium was directly measured against a D2O standard curve using a cavity ring-down water
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isotope analyzer (Los Gatos Research [LGR], Los Gatos, CA, USA) according to the published
method13.
Mass Spectrometry Sample Preparation
50-100 mg of mouse liver tissue was placed in 1.0 mL ammonium bicarbonate (ABC)
(25 mM, pH 8.5) along with protease inhibitor cocktail (Sigma, 1% v/v final concentration) and
homogenized using a MP Biomedicals FastPrep-24 bead homogenizer (2 x 3mm steel beads, 6
m/s for 60 seconds). Protein concentration of the homogenate was measured using a
bicinchoninic acid (BCA) protein assay (Thermo Fisher). For each sample, 50-100 µg of protein
was placed on a 30 kDa centrifugal filters (VWR), and 100 µL of a concentrated guanidine
solution (6 M guanidine HCl, 100 mM Tris-HCl pH 8.5) added to the sample. The filter was
then centrifuged at 14,000 x g for 15 minutes. This guanidine wash was repeated, and the flowthrough discarded. Disulfide bonds were reduced using a 10 mM dithiothreitol/6 M guanidine
HCl/100 mM Tris-HCl (pH 8.5) solution (100 µL total volume) added directly to the filters, with
an incubation of 1 hour at 60°C in a sand bath. Cysteine sulfhydryl groups were protected by
reaction with iodoacetamide (IAM, 20 mM) for 60 minutes in the dark. Afterwards, the samples
were centrifuged at 14,000 x g for 15 minutes, and the flow-through discarded. The samples
were then washed twice with ABC (200 µL, centrifuged 15 minutes at 14,000 x g), and the flowthrough discarded. Pierce MS-Grade trypsin was added (1:50 w:w) in 300 µL ABC to each
sample, followed by incubation at 37°C overnight. Resulting peptides were eluted by
centrifugation at 14,000 x g for 30 minutes, followed by a wash with 100 µL of ABC and an
additional centrifugation for 30 minutes at 14,000 x g. Filters were discarded and the filtrate was
dried using a speedvac (Sorval); the dried samples were stored at 4°C until use. With the
exception of diet A samples, which were HPLC fractionated (see Methods in Chapter 2), these
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samples were then resuspended in Orbitrap A buffer (0.1% formic acid (Pierce LC-MS grade) in
H2O (Optima grade Thermo Fisher)) to 1 µg/µL concentration in mass spectrometry vials for
measurement.
LC-MS Data Acquisition
MS data were collected on a Thermo Lumos Tribrid (Orbitrap) mass spectrometer.
Tryptic peptides were separated using a reverse phase C18 column (Acclaim PepMap™ 100) and
a Thermo Easy-Spray source. Mobile phase for the liquid chromatography was 0.1% formic acid
in H2O (Buffer A) and 0.1% formic acid in 80% acetonitrile (Optima grade Thermo Fisher) with
20% H2O (Buffer B) on an Easy-nLC 1200 HPLC system. Samples were eluted using a gradient
of 5% B to 22% B over 85 minutes, 22% to 32% B over 15 minutes, and a wash of 32% to 95%
B over 10 minutes, which was held at 95% B for 10 minutes. Sample loading and equilibration
were performed using the HPLC’s built in methods. MS only runs were performed using 2400 V
in the ion source, 60000 resolution with a scan range of 375-1700 m/z, 30% RF Lens,
quadrupole isolation, 8 *10^5 AGC target, and a maximum injection time of 50 ms. MS/MS
scans were performed using the same settings as MS only scans, with 3 seconds allowed per
MS/MS after each MS scan, using the following filters: peptide monoisotopic peak
determination, intensity threshold of 5*10^3, fragmentation of charge states +2 to +6, dynamic
exclusion that excluded a peak after being chosen once within 60 seconds, an error tolerance of
10 ppm high and low, and isotopes excluded. The fragmentation scan used an isolation window
of 1.6 m/z, CID fragmentation with an energy of 30%, detection in the linear ion trap in Rapid
Scan mode with an AGC target of 1*10^4, a maximum injection time of 35 milliseconds, and
used the “Inject Ions for All Available Parallelizable Time” option.
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Protein and Peptide identification
PEAKS Studio software (version 8.5) was used for de novo sequencing database
searching to identify proteins in the raw MS data14. Peptides were identified from MS/MS
spectra by searching against the Swiss-Prot mouse database (downloaded January 2018) with a
reverse sequence decoy database concatenated. Variables for the search were as follows:
enzyme was set as trypsin with one missed cleavage site. Carbamidomethylation of cysteine was
set as a fixed modification, while N-terminal acetylation and methionine oxidation were set as
variable modifications. A false positive rate of 0.01 was used to filter peptide and protein
identification results. Minimum length of peptide was set to 7 amino acids, and at least 2
peptides were required for protein identification. A mass error of 20 ppm was set for the
precursor mass, and the mass error was set as 0.3 Da for MSMS.
Calculation of Turnover Rates
Identification files from PEAKS and MS-only mass spectrometry data were analyzed
with the DeuteRater software package15, which provided the protein turnover rates used for later
analyses. The resulting kinetic data was filtered to remove data with extreme outliers or other
issues: First, rates that were greater than 1 or less than 0.03 were eliminated from further
analysis, as these rates represented extrapolations outside of the range of rates that could be
calculated confidently with the time points used in the experiment. Since the kinetic proteomics
data come from curve fits of relevant measurements, all curves with a Pearson’s R2 less than 0.5,
or with a covariance (standard deviation/rate value) of greater than 0.2 were also removed from
further analysis (the standard deviation was divided by the turnover rate for normalization).
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Quantitative Proteomic Methods
Quantitative Mass Spectrometry Sample Preparation
A mouse liver labeled according to a Stable Isotope Labeling by Amino Acids in
Mammals (SILAM) protocol (Lys6:13C, Cambridge Isotopes) was purchased and homogenized
as described in the “Mass Spectrometry Sample Preparation” section above. For each sample, 50
µg of protein from the SILAM homogenate was combined with 50 µg protein from the sample
homogenate (with the exception of the diet A samples; since these underwent HPLC
fractionation, 150 ug was used instead of 50 ug). Three biological replicates from each dietary
group were prepared. Since isotopic shifts caused by D2O labeling creates difficulties in peptide
identification, only 0-day and 1-day time point animals (measured from the date of
intraperitoneal injection of D2O) were used for this experiment. The mixtures of SILAM and
sample homogenates were otherwise prepared identically to those described within the “Kinetic
Proteomic Methods” section.
Mass Spectrometry Analysis
Samples were re-suspended to 1 µg/µL concentration in 0.1% formic acid. Samples were
analyzed on a Thermo Lumos Tribrid instrument paired with a Thermo Easy-nLC 1200 HPLC.
Solvent A was 0.1% formic acid, 100% water; Solvent B was 0.1% formic acid, 80%
acetonitrile, 20% water (all solvents were LC-MS grade). Gradient was as follows: 0-45 minutes
was 5-45% Buffer B, 45-50 minutes 45-100% Buffer B, 50-60 minutes 100% Buffer B. The MS
scans were collected at 60,000 Resolution, with 20 MSMS scans between MS scans. MSMS
fragmentation was done with a 1.6 m/z isolation window, and CID fragmentation with 28%
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fragmentation energy. Fragment ions were measured in the Linear Ion Trap with the “Normal”
resolution setting.
Data Analysis
SILAM Data was analyzed using the MaxQuant software package16 to quantify peptides
and proteins. All data was analyzed at the same time, with each dietary group analyzed as a
single experimental group. Constant modifications were carbamidomethylation for cysteine;
variable modifications allowed were oxidation of methionine and acetylation of the N-terminus.
The identification database was the same as that used for the kinetic analysis. Lys6 was added as
a heavy label; all other settings left at default. Unlabeled divided by labeled signal intensities
were determined and used to determine amounts of peptide in the sample relative to the SILAM
standard. The relative peptide abundances were then compared between samples.
DNA Turnover Rate Analysis
Since DNA turnover rate serves as a useful proxy for cellular division rate, we measured
the DNA turnover rates for all dietary cohorts by GC-MS using a previously published method12.
Briefly, DNA was extracted from 30-90 mg of frozen liver samples using the DNeasy kit
(Qiagen, Valencia, CA), and hydrolyzed to deoxyribonucleosides overnight at 37°C using S1
nuclease and potato acid phosphatase. The hydrolysates were reacted with pentafluorobenzyl
hydroxylamine and acetic acid, and then acetylated with acetic anhydride and 1methylimidazole. Dichloromethane extracts were dried, resuspended in ethyl acetate, and
analyzed via GC/MS on an Agilent DB-17 column with negative chemical ionization, using
helium as a carrier gas and CH4 as the reagent gas. The fractional molar isotope abundances at
m/z 435 (M0 mass isotopomer) and 436 (M1) of the pentafluorobenzyl triacetyl derivative of
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purine dR were quantified using ChemStation software. Excess fractional enrichment of D2O
was calculated relative to an unlabeled pentafluorobenzyl triacetyl purine derivative, and fraction
new DNA was determined for each sample by comparing excess fractional enrichment to the
calculated theoretical maximum. GraphPad Prism was used to perform least-squares fits to firstorder rate curves on plots of fraction new DNA versus time point. Standard deviation and
confidence intervals were calculated based on results from two biological replicates (each
measured three times) per time point. DNA turnover rates were analyzed and displayed using R
scripts17.
RNA-Seq
Following the manufacturer’s protocol, we used the Direct-zol RNA MiniPrep Plus kit
from Zymo Research to extract RNA from the liver tissue of all animals in this study. Briefly,
10-20 mg of frozen liver tissue from each mouse was processed using a Trizol extraction, and the
resulting RNA frozen at -80°C. Since we wished to identify changes in the transcriptome that
resulted only from dietary differences, RNA from three different mice in the same dietary cohort
sacrificed at different time points were pooled to form a single sample for RNA-Seq, thus
masking any differences resulting from temporal variations. There were three pools per dietary
cohort, containing RNA from three mice each (4ug of total RNA in 50 L of RNase-free water).
Each pool was submitted as a single sample to the BYU Sequencing Center. The BYU
Sequencing Center constructed cDNA libraries after a poly-A pull-down to enrich for mRNA,
and then sequenced the libraries using an Illumina HiSeq 2500 sequencing platform. RNA-Seq
gene count data were analyzed in R17 using the DESeq2 package18 (see Appendices) in
Bioconductor 3.3 from Bioconductor.org18, downloaded on October 20, 2016.
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Multi-omics Data Analysis
Global Versus Selective Regulation Determination
Linear regression analyses were performed on turnover rate (Figure 2), quantitative MS
(Figure 3), and RNA-Seq data (Figure 5). The global regression constants were used to calculate
expected values for each protein observed in the calorie-restricted (CR), calorie-restricted plus
AGEs (CR AGE), and calorie-restricted plus protein (CR PROT) cohorts relative to the “control”
diets: ad-libitum (AL) for CR, CR for CR PROT and CR AGE, and CR PROT for CR AGE.
This was done to identify protein specific regulation versus global regulation of the entire
proteome during calorie restriction, protein, and AGE dietary signaling. A paired t-test between
predicted and experimental values was then run using R scripting17 (see Appendices) for each
individual protein in CR vs AL, CR PROT vs CR, CR AGE vs CR, and CR AGE vs CR PROT,
for turnover rate, quantitative MS, and RNA-Seq data sets, generating a list of p-values for each
analysis. To reduce false positives, a q-value test was run in R17 using the qvalue package19 (see
Appendices) for each analysis, with an FDR level set to 0.01. Any proteins designated as not
significantly different were excluded from downstream analyses. A threshold of +/- 20% change
was used to further screen proteins that were significantly different from their predicted values;
these were divided into up- and down-regulated categories, respectively. Volcano plots
generated using R (Version 1.1.463)17 were used to display the results of these tests (see Figure
6).
Gene Ontology Analysis
Ontology groupings were determined using DAVID20,21. Proteins/gene lists were
obtained from the Global Versus Selective Regulation Determination analysis above. Ensembl
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IDs from RNA-Seq data were translated to UniProt accession numbers prior to ontology
analysis. Each category was input into DAVID20,21 against a background comprised of all
protein ID’s in that particular analysis (i. e. combined from up-regulated, down-regulated, and
not significantly different groups). Ontology groups with Benjamini-Hochberg coefficients less
than or equal to 0.05 were retained for analysis; all others were disregarded.
Ribosomal Subunit Analysis
Turnover rate and quantitative MS data for all of the ribosomal proteins was extracted from the
larger data sets, and separated into two categories based on whether the ribosomal protein was
part of the large subunit (60S) of the ribosome or the small subunit (40S) of the ribosome. A
Mann-Whitney non-parametric rank order test22 was performed using Microsoft Excel (version
14.7.7) on turnover and quantitative MS data to detect whether the large subunit was turning
over significantly faster or if its concentration was significantly lower than the small subunit.
One-tailed p-values of 0.05 or smaller indicated significance.
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Results
Calorie restriction resulted in a measurably distinct phenotype compared to ad-libitum controls.
Weight and movement for the mice were measured during the dietary treatments, and
mitochondrial respiration was measured immediately after sacrifice. Together, these
measurements provided some insight into the overall health of the mice and the outward effects
of the dietary treatments. Calorie restriction has been reported many times before to reduce
weight gain relative to ad libitum diets23, and we saw that effect in our study as well. In Figure
1, it can be seen that all of the mice gained weight over the 10-week course of the dietary
interventions; however, all of the calorie restriction cohorts gained weight more slowly than the
ad-libitum mice (AL). After 2 weeks, mice on diets CR, CR PROT, and CR AGE had all
become statistically significantly lighter than their AL counterparts; there were no statistically
significant differences in mouse weight between diets CR, CR PROT, and CR AGE throughout
the course of the dietary interventions. Since the dosage of additional protein and AGEs was
kept very low (0.14% w/w, see Methods) in order for the calorie restriction diets to be isocaloric, this was not particularly surprising.
Likewise, there was not much difference in the activity levels of the mice, measured over
twenty-four hour periods using a custom beam-crossing motion sensor assay. In the upper right
panel of Figure 1, only the AL and CR PROT cohorts were statistically different from each other,
suggesting that the protein addition to CR may have had a stimulating effect on mouse activity;
however, we have other data (not shown) from mice that were under dietary restriction rather
than calorie restriction that is very similar to the CR PROT activity level. Given that dietary
restriction and calorie restriction are often used interchangeably in the literature24, this suggests
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that, rather than being a real effect, stochastic effects in our measurements may be exaggerating
measured differences at the reported n values. Further verification is required before we can
confidently report that protein-augmented calorie restricted causes an increase in activity levels
of mice.
The mitochondrial respiration data (Figure 1, bottom two panels) showed the most
variation between the dietary cohorts. Pair-wise two-tailed t-testing showed that calorie
restriction was significantly different from CR plus protein (CR PROT) under the GM testing
conditions (mitochondrial leak) significantly different from all of the other diets under the D
testing conditions (ADP), and nearly statistically significant (p = 0.059) from ad libitum (AL)
under the S testing conditions (succinate). No other significant differences were found,
suggesting that the addition of protein or AGEs to calorie restriction affects mitochondrial
respiration, returning oxygen utilization by mitochondria to near ad-libitum levels (?).
Efficiency levels (Figure 1, bottom right) relative to GM suggest that CR decreases O2 flux
relative to ad-libitum, evidencing decreasing efficiency, and that the addition of protein or AGEs
to the CR diet mitigates this effect in the D (ADP) testing, but not in the S (succinate) testing,
indicating that the protein/AGE effect may be complex. However, the lack of significance
between the efficiency measurements makes this result suggestive only. More in-depth data on
the mitochondria at the protein level was required to confirm this organelle as a regulatory focus
node for calorie restriction.
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Figure 1: Mouse phenotype data. Mouse weight, movement, and mitochondrial respiration data are shown for the
four dietary cohorts. The upper left panel shows the weekly mouse weight data over the 10 weeks of dietary
treatment. Mouse weights were normalized to starting weights before averaging. The ad libitum cohort (AL) is
significantly different from the other three cohorts after week 2, but the three CR dietary cohorts were never
statistically different from each other over the course of the 10 weeks. The upper right panel is a dot plot of the
activity level of the mice; the only significant difference is between AL and CR PROT. The bottom two panels are
bar graphs displaying the mitochondrial respiration data of the dietary cohorts. “GM” is the mitochondria at rest
with oxygen, “D” is the addition of ADP and oxygen to show the function of the Electron Transport Chain (ETC)
excluding complex 2, and “S” shows complex 2 added to the rest of the ETC. The lower right panel displays the
relative efficiency of the ADP effect (D/GM) and the Succinate effect compared to mitochondrial leak (GM). All
error bars represent 95% confidence intervals.
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Calorie restriction results in decreased turnover rates. Protein- and AGE-supplemented calorie
restriction diets also have decreased protein turnover rates.
Our examination of the proteomes of the various cohorts began with a global look at
turnover rates. As shown in Figure 2, below, each of the three calorie restriction diets showed an
overall decrease in protein turnover throughout the proteome relative to ad-libitum diet (AL).
This is consistent with the results from the previous study using dietary restriction instead of
calorie restriction, and also correlates with other studies, showing the relative interchangeability
between dietary and calorie restriction24. Also consistent with the previous dietary restriction
analysis is the fact that the addition of protein (AGE-modified (CR AGE) as well as nonmodified (CR PROT)) perturbed the turnover rates less than unmodified calorie restriction (CR).
As with the previous dietary restriction study, this indicates a global slowdown of protein
metabolism in the cell.
Interestingly, CR PROT and CR AGE proved very similar to each other as well as to CR,
even though they are quite different when measured relative to AL. This is probably attributable
to the fact that proteins were matched only between the two diets being compared rather than
between all diets. Although this decreased the reliability between dietary comparisons, this was
more acceptable than matching the proteins across all of the diets, as this resulted in an
unacceptably small list (see Supplemental Data). Duplicating the analyses with the matched
proteins list resulted in very similar regression values.
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Figure 2: Turnover rate comparisons between dietary cohorts. In the top three panels, each of the calorie
restriction cohorts (y-axis) is compared with ad-libitum diet (x-axis) for proteins matched between the two diets in
each graph. In the bottom three panels, the three calorie restriction cohorts are compared to each other: CR PROT
vs. CR, CR AGE vs. CR, and CR AGE vs. CR PROT. Red dashed lines indicate linear regression fits (all slope pvalues << 0.00001 – see Table S2 in Appendices for regression line statistics), while dotted blue lines indicate
identity lines with a slope of one. Error bars indicate 95% confidence intervals.
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Calorie restriction may result in lower overall concentration of cellular proteins. Protein and
AGE supplementation did not significantly alter the CR protein concentration.
A global comparison of the protein concentrations across the proteome of the various
cohorts suffered from both very noisy data and small degrees of overlap between data sets, even
though a SILAC-based method was chosen to mitigate both of these effects (a label-free
quantitative MS data set had even poorer results (data not shown)). As shown in Figure 3 below,
although the three calorie restriction diets (CR, CR AGE, CR PROT) show consistently lower
overall protein quantity compared to ad-libitum diet (AL), poor correlation values between the
data sets makes this an unreliable measurement. This may be due to the fact that the AL sample
was fractionated by HPLC before measurement on the LUMOS Orbitrap, while the other three
diets were not. While this increased the number of protein identifications from the AL samples
significantly, such a difference in sample preparation may have introduced variables that made
the measurements more unreliable and noisy.
However, since the calorie restriction diet samples were prepared and analyzed
identically, the quantitative mass spectrometry measurement comparisons in the bottom row of
Figure 3 can be considered reliable. Despite the inability to use the AL data, it is still apparent
that there is little to no difference between the three calorie restriction diets. This suggests that
adding small amounts of protein or AGEs to calorie restriction has almost no effect on the
overall quantity of proteins in the proteome.
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Figure 3: Protein quantitative mass spectrometry comparisons between dietary cohorts. In the top three
panels, each of the calorie restriction cohorts (y-axis) is compared with ad-libitum diet (x-axis) for proteins matched
between the two diets in each graph. In the bottom three panels, the three calorie restriction cohorts are compared to
each other: CR PROT vs. CR, CR AGE vs. CR, and CR AGE vs. CR PROT. Red dashed lines indicate linear
regression fits (all slope p-values < 0.05 – see Table S2 in Appendices for regression line statistics), while dotted
blue lines indicate identity lines with a slope of one. Error bars indicate 95% confidence intervals.
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Differences in turnover rate and quantity of proteins are not due to changes in cellular division.
One possible cause for changes in protein turnover and quantity in a cell is dilution
through cellular division. To account for this, we measured the turnover rate of DNA within our
samples. Since DNA should only replicate once per cell division, the turnover rate serves as a
measurable proxy for the cellular division rate. One major advantage of our D2O isotopic
labeling method is that DNA becomes metabolically labeled similarly to proteins, and the
turnover rate can thus also be measured using mass spectrometry (described in detail in
Methods). The DNA turnover rates for ad-libitum (AL), calorie restriction (CR), calorie
restriction plus AGEs (CR AGE), and calorie restriction plus protein (CR PROT) are shown in
Figure 4 below. Although it is tempting to speculate that calorie restriction decreases cellular
division rates, and this is attenuated slightly by the addition of protein or AGEs, none of the
DNA turnover rates is significantly different from any other. Moreover, all of the DNA turnover
rates are much slower than the protein turnover rates measured in our study: the slowest protein
rates are an order of magnitude larger. We thus conclude that cellular division is not a major
factor in perturbations to protein turnover rate and quantity due to our dietary interventions.
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Figure 4: DNA turnover rate measurements. Average turnover rates are shown as fraction/day for DNA in diets
AL, CR, CR AGE, and CR PROT. Error bars indicate standard errors.
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Perturbations to protein regulation under calorie restriction are post-transcriptional.
In order to gain insight into gene expression regulation under calorie restriction
conditions, we conducted next-gen RNA sequencing (RNA-Seq) analyses on each of the dietary
cohorts. Relative expression of matched genes between dietary cohorts was then examined for
any significant differences. All of the dietary cohorts were extremely similar to each other,
indicating that the effects of calorie restriction, with or without additives, were due to changes in
post-transcriptional regulation. This correlates very well with the results of the dietary restriction
study in the previous chapter, and provides further support to a post-transcriptional hypothesis.
Unfortunately, while the data are useful for measuring relative gene expression levels within and
between data sets, normalization procedures in the data analysis procedure preclude making any
global RNA quantitative comparison; left unanswered is the question of whether the overall level
of mRNA in a cell goes up or down under calorie restriction conditions. It is possible that
mRNA in the cell could be affected globally, altering downstream global protein metabolism.
Future quantitative PCR (qPCR) or RNA quantitative mass spectrometry measurements are
necessary to address this possibility.
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Figure 5: RNA-Seq gene count comparisons between dietary cohorts. In the top three panels, each of the
calorie restriction cohorts (y-axis) is compared with ad-libitum diet (x-axis) for genes matched between the two diets
in each graph. In the bottom three panels, the three calorie restriction cohorts are compared to each other: CR PROT
vs. CR, CR AGE vs. CR, and CR AGE vs. CR PROT. Red dashed lines indicate linear regression fits (see Table S2
in Appendices for regression line statistics), while dotted blue lines indicate identity lines with a slope of one. Error
bars indicate 95% confidence intervals.
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In calorie restriction, mitochondrial and ribosomal protein regulation is significantly different
from global regulation of translation.
Thus far, the evidence from the proteomic and transcriptomic measurements indicated
that the entire proteome was experiencing a global shift in post-transcriptional regulation. While
this was not unexpected, and is indeed significant for the consideration of calorie restriction
mechanisms and effects, we asked whether any protein groups or organelles were being
perturbed differently from the global regulation, and what these could tell us about how calorie
restriction works in cells. To this end, we used the previous linear regressions to generate
predicted values for protein turnover rates, quant, and RNA-Seq counts: the control value for
each protein was input into the regression line formula as the x-value, and the output y-value was
computed as the predicted value for the other diet. These predicted values were then compared
to the actual values measured experimentally, and the difference between the predicted and
experimental values calculated and normalized, as detailed in the Methods. A paired student’s ttest was used to generate p-values, and a follow-up q-value test was used to minimize false
positives due to multiple comparisons. We then selected those significant results that fell 20% or
more outside of the predicted range for further analysis. The volcano plots in Figure 6 below
summarize this process graphically.

126

Figure 6: Experimental versus predicted values for turnover rates, quant, and RNA-Seq counts. Q-values for
the comparisons between experimental and predicted values for the various measurements are plotted on the y-axis,
while the x-axis shows fractional change between the experimental and predicted values. The horizontal dashed
blue line indicates a Q-value of 0.05 on the phred scale, and the red vertical lines indicate the cutoff of a +/- 20%
difference. Numbers of significant proteins are indicated; these numbers may or may not correlate with the
displayed points on the graph, as some of those displayed points were eliminated by the q-value test, but still
included in the graphic. Outliers past the ranges of the x-axis and y-axis are included in the numbers, but were not
displayed in order to keep the plot scales uniform. Calorie restriction (CR) versus ad-libitum (AL) is shown across
the top row, supplemented protein (CR PROT) versus calorie restriction (CR) is shown in the second row, CR AGE
versus calorie restriction (CR) is displayed in the third row, and the bottom row shows CR AGE versus
supplemented protein (CR PROT) calorie restriction.
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An ontology analysis using the online tool DAVID20,21 was carried out on the
significantly different protein groups, as described in the Methods. The results are shown in
Figure 7, below. Mitochondrial proteins were higher in quantity than the global prediction under
calorie restriction, while their turnover rates were lower than globally predicted. This indicates a
selective decrease in the degradation of mitochondrial proteins, possibly through the selective
slowing of mitophagy. This correlated well with the behavior of mitochondrial proteins in the
dietary restriction study of the previous chapter. Ribosomal proteins also displayed higher
quantity than the predicted values under calorie restriction, indicating that they may be protected
from the global slowdown of protein metabolism under calorie restriction. This also matched
well with the ribosomal proteins in the dietary restriction study, though they did not pass all of
the cut-offs for significant change in the dietary restriction ontology analysis. As in the dietary
restriction study, this suggests that the ribosome and mitochondria are regulated separately from
the global slowdown of protein metabolism in the cell under calorie restriction conditions in
order to preserve qualities of protein synthesis and energy metabolism that help the cell better
adapt to nutritional stress.
The ontology analysis did not reveal any enriched groups of proteins that were
significantly different between the calorie-restricted dietary cohorts (CR, CR PROT, and CR
AGE) in any of the data sets, as shown in Figure 7, below. Though disappointing, this confirms
the similarity between these groups that can be seen in the global measurements above, and
reinforces the conclusion that adding a small amount of protein or AGE to a CR diet does little to
alter the protein metabolism within the cell. Poor overlap of protein identifications between data
sets could also be a contributing factor, and though analysis filters were set conservatively to
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ensure high quality data, this may have had the effect of decreasing identifiable protein ontology
groups.
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Figure 7: Ontology analysis results. Proteins with experimentally measured values that were significantly
different from predicted values in the three data sets (see Figure 5 above) were input into the online tool DAVID20,21
for ontology analysis. Results after Benjamini-Hochberg correction with values of 0.05 or lower were judged to be
significant. These groups are listed in the table above, separated by dietary cohort comparison, measurement type,
and direction of change from predicted values. Box plots of the mitochondrial and ribosomal protein data for CR
versus AL are shown below the table; note that although “membrane” is listed as a significant ontology category,
most of these proteins overlapped with the mitochondrial classification, and were thus subsumed into the
mitochondrial category. An analysis using the unique proteins to the mitochondrial and membrane categories
showed no significant change in the non-mitochondrial membrane proteins from predicted values (?)(data not
shown).
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Ribosomal subunits show differential degradation rates in CR, CR plus protein, and CR plus
AGE dietary cohorts.
The dietary restriction analysis in the previous chapter revealed differential turnover and
quantity of the large versus the small subunit of the ribosome. We adapted the same analysis
here (a Mann-Whitney rank order test; see Methods) to see if a similar mechanism is present. As
expected, the same phenomenon was detected; interestingly, the difference in turnover and
quantity between the subunits appeared slightly exaggerated by the presence of protein or AGE
supplementation in the diets. This correlates with the dietary restriction study, in which we see a
greater difference between the subunits in the high protein diets compared to the low protein
diets. However, the low numbers of measurements in the quant-MS data mean that the
comparisons are not necessarily reliable. We have observed relatively large ranges for the
turnover and quant values for the ribosomal proteins; therefore the box plots for the quant data
cannot be compared at face value. The turnover rate data, however, is solid, and is consistent
with the translational modulation through differential ribosomal subunit degradation model
proposed in the dietary restriction study in the previous chapter.
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Figure 8: Ribosomal subunit data. Turnover rate and quant-MS data are shown for ribosomal proteins, separated
by location in either the large subunit or the small subunit. The numbers displayed at the medians of the box plots
show the number of measurements for the corresponding box plot (note the low numbers for the quant-MS data).
Notches indicate approximate 95% confidence intervals. Horizontal bars and asterisks indicate significance (onetailed p-values < 0.05).
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Mitochondrial, secreted, and endoplasmic reticulum proteins remain largely unperturbed by the
addition of protein or AGEs to calorie restriction.
In the previous dietary restriction experiment (Chapter 2), ontology analysis showed that
mitochondrial, secreted, and endoplasmic reticulum proteins were significantly changed versus
the global regulation. For comparison, these protein ontologies were analyzed for the calorierestricted groups in this study; the turnover data and quantitative MS data for these proteins are
displayed as ratios in Figure 9 below. CR AGE versus CR, as well as CR AGE versus CR
PROT, displayed no significant differences from predicted values (the poor match with the CR
PROT/CR comparison resulted in low numbers of ratios, and therefore cannot be relied upon).
Moreover, these ratios were not significantly different from each other. This implies that the
addition of AGEs or proteins does not result in significant perturbations to the regulation of these
protein groups. This correlates well with the global measurements from this study, and
reinforces the robustness of the calorie restriction regimen to small additions of dietary protein or
AGEs.

133

Figure 9: Mitochondrial, secreted, and endoplasmic reticulum protein rate and quant data. Turnover rate and
quant data for the proteins from the significant ontologies found in the previous chapter’s dietary restriction study
were extracted from the CR, CR PROT, and CR AGE cohorts. These are shown in the combined box and dot plots
above. Colored horizontal lines indicate the ratio of expected values based on regression lines from Figures 2 and 3.
Notches indicate approximate 95% confidence intervals.
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Discussion
The major goal of this study was to determine the proteomic effects of AGEs on the
calorie restriction diet. Given that AGEs are well-documented to elicit inflammatory reactions,
and high amounts of dietary protein is shown to be attenuating for calorie restriction benefits4,
we expected that AGEs should have a measurable effect on the protein metabolism within cells,
and that protein turnover rates and quantities would be significantly altered. Indeed, our own
data from the high-protein dietary cohorts in the previous chapter showed significant deviations
from the low-protein dietary cohort data. However, our results in the current study indicate that
calorie restriction is a robust phenotype that is not significantly altered by small additions (0.14%
by mass) of dietary protein or AGEs.
The calorie-restricted mice in our study exhibited the reduced overall protein turnover
rates we saw in the dietary restriction study (Chapter 2), validating the experimental conditions
of the AGE study, but this reduction carried over to the protein- and AGE-modified calorie
restriction diets as well. There were also no significant differences in protein quantity or RNA,
suggesting that any regulatory changes were minimal, and undetectable to the methods in this
study. Significantly upregulated or downregulated ontology groups, identified in both this study
as well as the previous dietary restriction study, were not significantly altered among the calorierestricted cohorts, showing that while selective as well as global regulation perturbations were
occurring under CR, they were roughly the same even with the addition of protein or AGEs.
There are several possibilities for the outcomes of this experiment. The first is that
factors in the experimental design may have prevented us from properly detecting and measuring
the proteomic impact of AGE signaling. The proteome coverage was not large (<10% of the
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estimated proteome for turnover rate and quantitative MS measurements), filtering of the data
decreased the coverage even further, and overlap between dietary cohort data sets for comparison
analyses was often very poor. Future experiments should seek to increase proteome coverage by
use of HPLC fractionation, increased replicate numbers, or improved instrumentation and data
analysis.
After all of the experimental animals were sacrificed, it was noted that two necessary
control groups, ad-libitum with AGEs, and ad-libitum with added protein, were never included in
the experimental design. This limited our downstream analysis somewhat (for example, would
there have been a change to the ad-libitum animal’s proteomes due to the addition of AGEs, and
how would this compare to AGE-mediated changes in calorie restriction?), but for logistical
reasons, it was not possible to add these control groups afterwards.
The dosage of additional protein and AGEs was very low (0.14% by mass), which likely
muted the effect of the dietary additions. The addition of greater amounts of dietary protein and
AGEs to the experiment is expected to magnify any proteomic effects of these additions (e. g. the
high-protein cohorts from the previous study showed measurable differences to the low-protein
cohorts, and the difference in dietary protein was nearly two-fold), but would complicate the
ability to keep the various calorie restriction diets iso-caloric, as well as introduce other variables
associated with decreasing the other sources of dietary calories. A nutritional geometry
approach, as proposed by Simpson and Raubenheimer25, may be necessary to deconvolute
dosage effects of dietary protein and AGEs. This would also be informative as to the mechanism
of AGE-mediated attenuation of calorie restriction: are these molecules acting primarily as
signals (low-dosage is sufficient, with a plateau at higher levels), as an alternative fuel source
(dosage-dependence, with magnified effects at high levels), or other mechanism (perhaps
136

evidenced by a maximal effect at a moderate concentration)? A metabolic labeling experiment
involving isotopically labeled AGEs would also shed light on the mechanism (i. e. the presence
of the isotopic label within other molecules in the cell would be dependent on pathways involved
in AGE metabolism).
Future studies may also examine AGE signaling on other organs, such as the brain,
spleen, kidney, and lung. Our study focused only on the liver, as it has several advantages for
such a proteomics study: it is large, relatively homogeneous, and central to organismal
metabolism. The lung would be especially interesting, as it is known to have more receptors for
AGEs (RAGE) than any other tissue in the body26; a comparison study with brain, spleen, and
kidney, combined with the liver results would likely demonstrate different ranges of sensitivity
and effects from dietary AGEs in various parts of the body. It may even be possible to show in
which organ the attenuation of lifespan observed with AGE consumption first begins.
In summary, this study provided evidence that calorie restriction causes a robust
proteome remodeling that is resistant to small amounts of AGEs. The dietary signaling effect of
these molecules at low dosage was not sufficient to significantly perturb the protein metabolism
of liver cells under CR. Future studies will be necessary to establish a dosage threshold for the
AGE effect, and elucidation of the AGE-mediated lifespan-attenuating mechanism.
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Supplemental Data
Matched Protein List Analyses
In the analyses of the turnover rate (Figure 2), quant MS (Figure 3), and RNA-Seq data
(Figure 5), proteins were directly matched between the two dietary cohorts being compared
without regard for matching proteins to other dietary cohorts. This was done to ensure maximum
overlap between the two tested cohorts and improve the quality of the direct comparison. The
alternative analyses, with matched proteins between all sets, are shown below (Panels A, B, and
C); the number of proteins that matched, 59, was judged too small to replace the previous
analyses. The alternative analyses are otherwise identical to those in Figures 2, 3, and 5. An
ontology listing using DAVID20,21 for the 59 proteins was generated (entire mouse proteome
used as background, Benjamini-Hochberg < 0.05 for inclusion), so that functional clustering/bias
could be evaluated for these proteins. 28 of the proteins clustered as mitochondrial, so this group
of proteins cannot necessarily be interpreted as representative of the cell as a whole. Despite
this, the matched protein analyses, with the exception of the AL quant MS data (Figure B, top
panels) resulted in linear regression constants that are very similar to the values calculated using
the more inclusive direct comparison analysis method (Figures 2, 3, and 5).
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A. Turnover Rate Data
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B. Quant MS Data
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C. RNA-Seq Data
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CHAPTER 4
“Imaging Regiospecific Lipid Turnover in Mouse Brain with Desorption Electrospray Ionization
Mass Spectrometry”
Although this chapter represents a departure from proteomics into lipidomics, with the
development of an imaging method using desorption electrospray ionization mass spectrometry
(DESI-MS) to make kinetic measurements, the ultimate goal is still to deduce the regulation of
proteostasis through the application of combined-omic technologies. In this study, we
demonstrate the potential for measuring turnover rates in a two-dimensional tissue imaging
technique, allowing for the separate analyses of synthesis and degradation of biomolecules. We
began with lipids, as these were the easiest to detect and quantify, but future method
development is expected to result in techniques that allow the measurement of proteins.
Turnover and quantification measurements of proteins in a regiospecific manner would enable
proteostatic analyses similar to those in the preceding chapters, but expand them to tissue- and
organ-wide scopes that would also encompass extracellular functions. Data on this scale could
then be combined to inform a holistic view of organismal phenotype dependent upon
homeostatic controls that vary from tissue to tissue and organ to organ. Ultimately this would
have the potential to link broad symptoms of disease to specific shifts in metabolism that can be
studied in a systems-wide manner, uncovering information that would escape a cell-centered
focus, providing access to previously untapped discovery grounds for novel diagnostic tools and
therapies.
This paper was published in the Journal of Lipid Research in 2017. My contributions to
the project included mouse work; tissue sample preparation; collaboration in initial method
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development; participation in instrument development, operation, and trouble-shooting;
identification of lipid targets, and subsequent verification by mass spectrometry fragmentation;
and preparation of some figures for the manuscript. The document has been altered slightly to
conform to the format of this dissertation, and figures have been renumbered to adjust for the
incorporation of supplemental figures in the body of the main text. The paper is otherwise
identical to the published version.
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Abstract: Compartmentalization of metabolism into specific regions of the cell, tissue and
organ, is critical to life for all organisms. Mass spectrometric imaging techniques have been
valuable in identifying and quantifying concentrations of metabolites in specific locations of
cells and tissues, but a true understanding of metabolism requires measurement of metabolite
flux on a spatially resolved basis. Here we utilize desorption electrospray ionization mass
spectrometry (DESI-MS) to measure lipid turnover in the brains of mice. We show that
anatomically distinct regions of the brain have distinct lipid turnover rates. These turnover
measurements, in conjunction with relative concentration, will enable calculation of regiospecific
synthesis rates for individual lipid species in vivo. Monitoring spatially dependent changes in
metabolism has the potential to significantly facilitate research in many areas, such as brain
development, cancer, and neurodegeneration.
Keywords: arachidonic acid, brain lipids, DESI, diet and dietary lipids, diagnostic tools,
kinetics, molecular imaging,
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Introduction
Lipid biosynthesis occurs in every cell and is a critical process for life. Lipids act as structural
components, essential nutrients, and signals for processes as diverse as cell proliferation or
apoptosis 1. Many lipids within the body are synthesized locally 2. Certain classes of lipids,
though, cannot be synthesized by mammals 3, and some cells, like neurons, do not produce
enough lipids to serve their needs. Therefore, dietary lipid availability and transport of lipids
within the body are critical components of metabolism. Lipid transport is closely linked to
multiple diseases, including heart disease and Alzheimer’s disease 4.
By measuring lipid abundance across a tissue surface, one can create images composed of lipid
type and concentration 5. Imaging lipids within the structure of the brain and other organs has
been used extensively to understand response to injury 6, and to detect cancers 5a, 5b, 7. Here we
have used the Desorption Electrospray Ionization (DESI) imaging technique. In DESI, a fine
spray of charged droplets in a high-velocity gas jet is directed toward a tissue sample (Fig. 1).
Dissolved analytes from the tissue become ionized, and are pulled into the mass spectrometer
(DESI-MS)8. The mass spectrometer records the mass-to-charge ratio and intensity as the spot
where the spray hits the tissue is rastered over the tissue surface. By correlation of the timedependent mass spectrometric data with the motion of the tissue on a computerized stage, an
image can be constructed that displays the types and relative concentrations of analytes at
specific positions in the tissue sample.
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Desorption Electrospray Ionization (DESI)
Desorption Electrospray Ionization (DESI)
Solvent
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Figure 1: Desorption electrospray ionization (DESI) is an ambient ionization mass spectrometric imaging
technique. Electrospray droplets are formed when high voltage is applied to the solvent. Desorbed analyte is
vacuumed into the mass spectrometer inlet, separated by m/z, and detected. After the sample is slowly rastered
beneath the DESI source and mass spectrometer inlet, an image of the sample surface can be recreated from the
mass spectral data.

Changes in lipid types or concentrations allow boundaries between tissues as well as regions
within the tissue to be identified 5, 7. The spectra from modern high-resolution mass
spectrometers are exceptionally information rich, but even so, positive identification of all ions
in a spectrum is rarely possible, and it is often difficult to unambiguously assign peaks to
individual lipids 9. As a result, many studies have been published using changes in unidentified
features to differentiate between areas of an image 5b, 5c. Even with this limitation, DESI-MS
imaging has recently been shown to improve the efficacy of cancer surgery by highlighting the
boundaries between tumor and healthy tissue 5, 7.
An advantage of identifying and focusing on discrete lipid species when they can be positively
identified is that we can assess the activity of biological pathways that produce those lipids. This
is particularly useful in developing a rational intervention to prevent developmental defects, and
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treat cancers or degenerative diseases. Trying to evaluate enzyme activity using only in vivo
concentration is problematic because the body modifies synthesis and degradation rates to resist
changes in concentration. Therefore measurement of in vivo rates is the most sensitive method
for detecting changes in metabolism 10 and may allow prognostic diagnosis of developing
problems.
Here we show that using DESI in conjunction with metabolic labeling, we can measure turnover
of individual lipid species in the mouse brain (Fig. 2). Further, we show that the turnover rates
vary between physiologically recognizable structures. Although a large number of compounds
can be detected in the mass spectra, in this proof of principle study we limited the analysis to
four identified lipids. In principle this analysis can be conducted on large numbers of lipids
simultaneously, and will be particularly useful in detecting fast growing tissues like cancer
within the context of healthy tissues.
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Materials and Methods

Figure 2: The workflow is shown here in chronological order. First, mice are fed 8% deuterated water over a
course of different time periods to increase their deuterium concentration in the lipids within their bodies. Then the
mice are euthanized, their organs are sliced to 50 μm thick, and the slices are thaw mounted on glass slides. The
desorption electrospray ionization (DESI) source is rastered over each tissue slice over a period of approximately
two hours. The mass spectral data files are converted initially from .d files to a MATLAB data cube. Individual m/z
peaks are selected to see the spatial and regioselective nature of individual lipids. Isotope ratio images reveal
differing lipid turnover rates within the organ structure for individual lipids, which are measured using incorporation
curves.

Metabolic labeling
All experiments were performed under the approval of the Institutional Animal Care and Use
Committees of Brigham Young University in conformity with the Public Health Service Policy
on Humane Care and Use of Laboratory Animals. Female mice (C57/Bl6:Spt2) between the ages
of 13-16 months were housed in groups of five. To initiate the experiment all mice received an
intra-peritoneal (IP) injection of saline deuterium oxide (0.9% w/v NaCl, 99.8% D2O), 15 μL
saline per gram body weight. After the IP bolus, mice were provided free access to food and
deuterium enriched drinking water (8% molar enrichment) for the remainder of the experiment
(Fig 2). This method caused an initial jump in deuterium enrichment up to 2 molar percent
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excess (MPE) to initiate the experiment, followed by a rise to 5 MPE over the next 10 days.
Urine was collected up to 10 days during the labeling period to build a profile of deuterium
enrichment in each animal (Fig. 3). At the designated time points (0, 1, 5, 10, 20 and 40 days
post IP), mice were anesthetized with carbon dioxide, and then euthanized via cardiac puncture
to collect blood. Brain tissue was immediately collected. Cells were removed from the blood
plasma via centrifugation (10 minutes at 800xG at 4°C). Brain tissue and blood plasma were
flash frozen on dry ice and stored at -80 °C until needed.

Figure 3: Urine and blood deuterium enrichments for the mice used in this study were combined to measure
an average body water turnover for these mice. There was an initial bolus to 2.1 molar percent excess (MPE),
followed by an increase to 5.3 MPE. Body water turnover rate was 0.27 per day, resulting in a body water half-life
of 2.5 days in these mice. This body water turnover rate was used to define a curve of deuterium enrichment for
calculating turnover of the individual lipids.

Measurement of deuterium enrichment
Blood plasma and urine isotopic enrichments were measured in duplicate for all time points. In
preparation for this measurement, aliquots of each sample were diluted in duplicate (1:300 in 18
MΩ water) and placed into the caps of inverted sealed screw-capped vials for overnight
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distillation at 80°C. Similar to previous studies, the MPE deuterium in the distilled water was
measured against a D2O standard curve using a cavity ring-down water isotope analyzer (Los
Gatos Research [LGR], Los Gatos, CA, USA) according to the published method 11.
Cryosectioning
Brains were cut coronally immediately after dissection and flash-frozen on dry ice. To obtain
slices for DESI, frozen forebrains were adhered using VWR Clear Frozen Section Compound to
the chuck of a Cryostat Thermo Scientific Microm HM550, and flash-frozen in liquid nitrogen.
50 μm sections were sliced at -15 °C. Sections were thaw-mounted onto VWR Superfrost Plus
glass slides, flash-frozen on dry ice, and stored at -80 °C. Prior to DESI imaging, the glass slides
were dried at slight negative pressure for approximately 20 min at room temperature, as
previously described 12.
DESI-MS data acquisition
Sample images were gathered using a MicrOTOF II (Bruker Daltonics, Billerica, MA, USA) and
a laboratory constructed DESI source. DESI parameters are presented in Table 1. Together, those
parameters created a solvent spot that desorbed lipids and fatty acids from the brain tissue,
releasing them into the atmosphere, where they were sampled by an extension to the capillary
inlet of the mass spectrometer.
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Table 1. Instrumental parameters for DESI image acquisition

DESI Source
Emitter voltage

-5kV

Solvent

100% methanol

Solvent flow rate

2.5-3.0 µl min-1

N2 gas pressure

160 psi

Emitter angle

55 degrees

Emitter tip to surface distance

1 mm

Emitter tip to inlet distance

4 mm

Stage Parameters
x-axis scan rate

75 µm sec-1

y-axis row spacing

150 µm

Mass spectrometer parameters
Ion mode

negative

Mass range

200 m/z to 900 m/z

Acquisition rate

1 spectrum sec-1

Averaging

2 spectra

Inlet voltage

500 V
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DESI image quality considerations
Acquisition of high-quality DESI images requires careful attention to a large number of
experimental parameters and inevitably requires a compromise between sensitivity and spatial
resolution 13. The experimental parameters presented in Table 1 represent such a compromise.
The nominal pixel size was 75 μm × 150 μm. Additional important considerations include the
complete elimination of gases from the solvent, the shape of the mass spectrometer inlet
extension, and the age of the sample tissue 13b. Since no preventive measures were taken to keep
the brain cells intact at the surface of the tissue slices during cryosectioning, the DESI-MS data
represent an average of all membrane and cytosolic lipid populations.
Analysis workflow (Image Inspector)
Acquisition files from the Bruker MicroToF were converted from .d files to .imzML using
ProteoWizard MSconvert 14. The imzML was then converted to a data cube using a MatLab
script adapted from the read_imzML script that was included as part of the omniSpect package
published by the Fernandez group at Georgia Tech 15. It is worth noting that, despite attempts to
ensure that imzML is a universal format, the imaging files derived from different proprietary
manufacturers’ formats have idiosyncrasies that require attention when reading them into a
custom software package. For example, the number of spectra in chronograms acquired by the
Bruker instrument varies by one because of a lack of synchronization between an external start
signal and the internal clocking of the data acquisition. We provide the imzML-to-cube script as
a template for other users, but it has only been tested with Bruker data.
After creation, the brain data cube was then assembled into an image using a MatLab script we
developed called Image Inspector (Fig. 2). Image Inspector allows flexible manipulation of the
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data cube to examine and export mass spectra from individual pixels or regions of interest, to
view and export concentration maps for selected masses, and to view and export maps of
neutromer ratios. Portions of Image Inspector were also adapted from the omniSpect library.
Areas defined by a region of interest tool were summed for export and calculation of isotope
labeling. Turnover kinetics of individual brain regions in each image were calculated from the
time-dependent ratio of labeled to unlabeled lipids. The code and readme for installation and
usage of the Image Inspector tool are provided as supplementary information.
Identification of individual lipids
In order to verify the lipid identities, purified lipids were ordered from Sigma-Aldrich and used
as standards: arachidonic acid (A3611-10MG); cis-4,7,10,1,16,19-docosahexanoic acid (5317110MG); 1,2-diacyl-sn-glycero-3-phospho-L-serine (P7769-5MG); L-alpha-phosphatidylinositol
ammonium salt solution (P2517-5MG). While the AA, DHA, and PI standards were exact
matches for the lipid identifications we tested, it is worth noting that the PS standard turned out
to be a different phosphatidylserine species, with a lower molecular weight than the one we
observed in our DESI brain scans. For DESI scanning, a few drops of standard in solution
(~10mg/mL in chloroform) were placed onto VWR glass slides via pipette, and fragmentation
was accomplished as described below for the brain slices.
MS/MS fragmentation spectra (Fig. 4) were collected in negative ion mode for ions at 303.25,
327.25, 834.5 and 885.6 m/z, using an Agilent QToF mass spectrometer equipped with a DESI
source. A metabolically unlabeled 50 μm thick brain slice was scanned in targeted MS/MS mode
three times at each of three different collision-induced dissociation (CID) fragmentation energies
(10, 20, and 40 EV). Nitrogen was the collision gas. Each scan lasted approximately 3 minutes;
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during the scans, the brain slice was manually moved under the DESI spray (100% methanol at 3
mL/min.) in order to maximize total ion counts. The capillary voltage was set at 1000 V, and
MS1 and MS2 data were collected at a maximum rate of 4 spectra/second (other settings: 250
MS/spectrum, narrow isolation width ~1.3 m/z). Fragmentation data at each collision energy
were averaged to collect the MSMS spectra (supplemental information); experimentally
observed fragments for tissue and standards were initially compared against the literature 8b, then
further analyzed using online tools from LipidMaps.org 16 and Metlin.Scripps.edu 17 to identify
each of the lipid species.
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Figure 4, A-D: Lipid fragmentation from brain samples compared to standards. Fragmentation spectra for
lipids at 303.3, 327.3, 834.6, and 885.6 m/z at 40 eV collision energy (top spectra, each panel) matched with
fragmentation spectra for the corresponding commercial lipid standards (bottom spectra, each panel, inverted) under
identical DESI conditions.

Figure 4A: Fragmentation of 303.25 m/z peak and arachidonic acid standard. Despite not being able to identify
structures to accompany all fragments, good agreement between sample and standard spectra allow us to confidently
identify the lipid at 303.25 m/z as arachidonic acid.
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Figure 4B: Fragmentation of 327.3 m/z peak and docosahexaenoic acid standard. Despite not being able to
identify structures to accompany all fragments, good agreement between sample and standard spectra allow us to
confidently identify the lipid at 327.3 m/z as docosahexaenoic acid.
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Figure 4C: Fragmentation of 834.6 m/z peak and phosphatidylserine standard. Although the PS standard was
not an exact match for the target in the brain samples (parent ion m/z of 788.5, see Methods), the lipid standard
enabled us to confirm that the species at 834.6 m/z is a phosphatidylserine.
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Figure 4D: Fragmentation of 885.6 m/z peak and phosphatidylinositol standard. Despite not being able to
identify structures to accompany all fragments, good agreement between sample and standard spectra allow us to
confidently classify the lipid at 885.6 m/z as a phosphatidylinositol.

Calculation of the number of deuterium sites (n)
As we18 and others19 have previously described for peptides, independent turnover rates can be
measured for multiple analytes simultaneously using mass spectrometry and D2O labeling. The
three main variables to consider when calculating the turnover rate (k), are the number of sites in
each lipid that can incorporate deuterium from water (n), the D2O enrichment of the body water
at the time the lipid was labeled (p), and the time-dependent labeled fraction (f) of the lipid being
measured (32).
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Table 2. The common name, observed ionic mass, and elemental composition of the 4 major singly charged
ions observed in our DESI-MS spectra. The asterisk (*) next to the name indicates a statistically significant
difference in the turnover rate (k) of lipids between the caudoputamen and cortex. The number of deuteriums (n)
was the same regardless of the area of the brain. There were large differences in the amount of biosynthesized versus
dietary lipid (%) for different lipid species.
Lipid

m/z

Formula

n

k in CA

k in CO

%

arachidonic acid, *

303.25

C20H32O2

6

0.046±0.005

0.055±0.007

40

DHA,

327.25

C22H32O2

~8

0.057±0.019

0.045±0.010

32

phosphatidylserine, *

834.6

C46H77NO10P

21

0.041±0.003

0.053±0.001

100

phosphatidylinositol

885.6

C47H82O13P

27

0.072±0.005

0.081±0.005

73

The number of covalent deuterium sites (n) is unique for each lipid (Table 2). This value was
calculated using the isotope pattern for the metabolically labeled form of each identified lipid
and the known D2O enrichment (Fig. 5). Highly labeled spectra for the individual lipids were
collected by imaging brain tissue from mice collected after 40 days. We subtracted the unlabeled
isotope pattern from the labeled spectra to isolate the specific changes due to the newly
synthesized lipid. We found that using an experimentally-determined unlabeled background
improved the calculations. We then calculated the deviation assuming a range of n values for the
lipid. Three of the four lipids had a single best n which minimized the deviation between theory
and experiment for each of the isotope peaks within the isotope pattern (Fig. 5) as previously
described 18, 20. DHA had a very small overall change in the isotope pattern that is affected by
interference from nearby molecules. We were not able to find a unique best n value for DHA.
Calculating in vivo lipid turnover
Every time a new lipid is synthesized it will incorporate protons and deuterons from the body
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water pool. The relative percentage of deuterium incorporated is dependent on the enrichment of
the water at that time. The changing deuterium enrichment of the body water in these mice
required that the effective deuterium enrichment be calculated based on the half-life of the
analyte. Because human studies usually have an increasing non-linear body water enrichment 18b,
19b

, this study provided a good proof-of-principle test for the calculations that would be required

for analyzing metabolically D2O-labeled human tissue samples. The enrichment of the body
water for this calculation was defined as the average of the urine and plasma values for all mice
at a time point (Fig. 3). This body water curve provided the time- dependent precursor
enrichment for the calculation of the f values. The time-dependent change in normalized
intensity Ix for each mass in the neutromer pattern was calculated according to equation 1, for
both experimental and theoretical spectra. As the initial point for the Bayesian calculation of k,
we calculate the theoretical Ix for the labeled molecule using the body water measured that day.
The daily f values were then calculated using the single pool rise to plateau kinetic shown in
equation 2. The half-life from this initial k value was then used to calculate the effective body
water at each time point as the integral over that time period, which was used to calculate new
theoretical Ix and a new f as described previously for protein 18b. These f values were used to fit
a new k, which was used to calculate the new effective deuterium enrichment for the next round.
This recursive optimization was conducted until the lipid half-life changed by less than 0.5 days.

Equation 1:

Equation 2:
We compared k values in the cortex and caudoputamen of the brain by averaging the spectra in
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those regions using Image Inspector, then calculating k using the scipy package in python for the
recursive, non-linear regression fit.
Results
Establishment of lipid identities and n values
In the DESI spectra, four singly-charged ions were consistently observed with significant signal
intensities (Fig. 5).

Figure 5: Comparison of experimental and optimized simulations of labeled and unlabeled spectra(A). The
number of deuterium sites was derived by minimizing the deviation between the simulated and experimental spectra
when the number of covalant deuterium sites was allowed to vary (B).
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We compared the parent m/z and MS/MS fragmentation data (Fig. 4) observed here against a
literature source 8b and tentatively identified them as arachidonic acid (AA, C20:4 5,8,11,14,
m/z = 303.25, C20H32O2), docosahexaenoic acid (DHA, C22:6 4,7,10,13,16,19, m/z=327.3,
C22H32O2), phosphatidylserine (PS, C40:6, m/z=834.6, C46H77NO10P), and phosphatidylinositol
(PI, C38:4, m/z=885.6, C47H82O13P). Subsequent MSMS fragmentation of purified lipid
standards verified the identification of AA, DHA, PS, and PI (Fig. 4).
The calculated n value for each of the lipids (Fig. 5) is consistent with their individual
biosynthetic pathways. AA and DHA are both conditionally essential fatty acids. They are
synthesized from the essential fatty acids linoleic (C18:2 D9,12) and lineolenic acid (C18:3
D9,12, 15) respectively, but can also be obtained through the diet. Our results suggest that the
addition of the C2 unit to make AA from linoleic acid includes the covalent addition of 6 protons
from water (Fig. 6). During deuterium enrichment these 6 positions can incorporate deuterium
leading to the n=6 value for this lipid (Fig. 5). DHA was less clear because the spectra were
noisier, and the experimental I was very small. The change at M2 for DHA was confounded in
many spectra by overlapping peaks from unidentified species. Although there were multiple n
values mathematically (Fig. 5), the similarity to the AA biological pathway suggested that an
n=8 value would be most appropriate (Fig. 6). It is highly likely that the PS and PI spectra
represent two families of related structures where the unsaturated bonds are at multiple different
positions in the fatty acyl tails. Our DESI fragmentation method was not capable of
distinguishing between specific isomers that differ only in the placement of double bonds.
However, in spite of this potential structural variation, we were able to calculate an n value of 21
for PS and 27 for PI (Fig.3). The glycerol backbone and the head groups of these lipids are
synthesized from glucose, which would allow each of the carbon hydrogen bonds to incorporate
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a deuterium 2a. For PS, this means that up to 8 deuterium positions are within the glycerol and
serine. The 13 other deuterium sites are presumably distributed between the two fatty acyl tails.
The inositol head group in PI and two fewer desaturations in the fatty acyl tails could easily
account for 6 more deuterium positions observed in this molecule (Fig. 6).

Figure 6: Stable carbon hydrogen bonds which could incorporate deuterium during metabolic labeling are
indicated with asterisks. The biologically predicted number of deuterium sites are close to the theoretical
expectations based on the biosynthesis of AA and DHA. Because of the isobaric diversity that is likely present for
the PS and PI lipids, it is not possible to specify the deuterium incorporation sites for these lipids in the hydrophobic
tails.

Spatially distinct changes in isotope ratio are specific to individual lipids and independent
of concentration
In the DESI images, signal intensity at a given m/z value is a measure of the relative
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concentration of a particular compound (the neutromer distribution is a measure of the turnover
of that compound). In addition to depending on the concentration of a compound in the tissue,
DESI signals can be affected by a range of factors, including the tissue type, microscopic surface
roughness, and changes in ambient conditions during image acquisition. Even with this inherent
variability, the spatial distribution of lipid signal intensity was distinct for each targeted lipid and
followed boundaries of the classical brain structures in a manner that is consistent with changes
in concentration. Measurement of PS intensity in tissues collected throughout the metabolic
labeling time course (Fig. 7, right column) showed that its concentration was consistently
relatively high in the cortex and the caudoputamen, and lower in the corpus callosum.
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Figure 7: Concentration/isotope ratio images for phosphatidylserine. A representative stained tissue slice is
shown (top left), with the areas of the cortex and caudoputamen (CA) highlighted in the cartoon (top right).

Comparison of the change in intensity with change in isotope ratio for the four test compounds
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across an image, shows that they are not necessarily linked for the different lipid species (Fig. 7,
Fig. 8). Using PS as an example, if the change in isotope pattern is scaled linearly over the 40
days of the experiment (Fig. 7, global scaling), we see similar changes across the entire brain.
This similarity suggests that newly synthesized lipid is present across the entire organ. Changing
the scaling of the image to emphasize the range within a single image (independent scaling)
shows that there is a small, but measurably faster rate in a subsection of the cerebral cortex and
the septal nucleus. Importantly, the symmetry of the image is in agreement with the structure of
the brain, reducing the possibility that this is a transient fluctuation in the image. The turnover
measurement of each lipid is much more resistant to variations in ionization efficiency, because
the heavy and light versions of the lipid are chemically identical and change similarly, preserving
the ratio between them. This means that the turnover measurement is in principle more robust
across an image than simple concentration measurements.
Figure 8, A-C: Concentration as the relative ion intensity (right hand column), and isotope ratio images
scaled either within the timepoint (right column) or across all the timepoints (middle column) for arachidonic
acid (AA, S4A), docosahexaenoic acid (DHA, S4B), and phosphotidyl inositol (PI, S4C). A representative
stained tissue slice is shown (top left), with the areas of the cortex and caudoputamen (CA) highlighted in the
cartoon (top right).
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Figure 8A: Concentration/ Isotope maps for AA
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Figure 8B : Concentration/ Isotope maps for DHA
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Figure 8C : Concentration/ Isotope maps for PI. The other lipids all showed similar, yet unique distributions in
both concentration and turnover rate. AA, for example, is found at relatively high concentrations everywhere in the
brain except the caudoputamen area (Fig. 8A). The rate of turnover was also slower in the caudoputamen. This is
consistent with the idea that AA is synthesized and degraded locally. DHA is found at relatively high concentrations
in the cortex, but there is a very small and somewhat noisy change in the isotope ratio, suggesting that turnover is
minimal anywhere in the brain (Fig. 8B). This is not surprising, given that DHA is conditionally essential in the diet,
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but these results suggest that 65% of the DHA in the brain is sourced directly from the diet. PI has a similarly wide
distribution of relatively high concentrations in the brain, except in the approximate area of the corpus callosum
(Fig. 8C). Interestingly, the turnover of this lipid is fastest in the corpus callosum where the concentration is very
low. This suggests that the lipid is either synthesized and immediately degraded in the area of the corpus callosum,
or that it is synthesized and distributed to the rest of the brain from the corpus callosum.

Turnover calculations highlight differences in metabolism between lipids
Using the lipid-specific n value and the measured body water, we can calculate the timedependent percentage of the molecules that have been labeled. This allows us to directly
compare metabolic rates between the different lipids. We found that using the average body
water curve and combining all the time dependent measurements from the individual mice to
constrain the turnover calculation dramatically improved the confidence in the fit. This is
consistent with the fact that these mice were all genetically identical and of a similar age.
Therefore, they can be considered biological replicates for these metabolic measurements.
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Figure 9: Deuterium enrichment of all four lipids included was compared in different areas of the brain. The
distribution of enrichment in individual pixels in the Cortex (gray inset) versus the Caudoputamen (black inset)
varied according to lipid and area of the brain (Day 20 shown). Turnover rates were calculated using kinetic curves
composed of 3 separate images from 2 mice at each time point.

As suggested by the images (Fig. 7, Fig. 8), we found that there was a small but measureable
difference in turnover rate between different regions of the brain for the lipids AA and PS (Fig.
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9, cortex vs caudoputamen). PI turned over more rapidly than the others and did not have a
significant difference between the cortex and caudoputamen (Table 2). Interestingly, the turnover
kinetics also highlighted differences in the source of the lipids. For example, the incorporation
curve for PS had a rate of approximately 5% per day and increased over the 40 day experiment
such that ~100% of the lipid was new by the final measurements. PS is evidentially formed from
fully biosynthesized precursors, while the majority of AA and DHA are sourced from the diet.
PS, AA, and DHA curves had similar rates of incorporation (~5% per day), but the amount of
labeled AA and DHA saturated at much lower amounts than PS (Table 2). The saturation
percentage reflects the relative contributions of biosynthesis and dietary sources for each lipid
species. De novo synthesis and dietary sources of lipids are known to both be critical for the
development and health of the brain 3a. The uniform kinetic plateau across the image for each
lipid also suggests there is no spatial differentiation in the source, i.e. diet versus de novo
synthesis.
Discussion
We have shown that DESI can be used to image spatial regulation of metabolism in the mouse
brain. Although any imaging technique could potentially be used to monitor metabolism using
these methods 5c. DESI is convenient as an imaging system because the sample preparation is
fast and inexpensive, with simple atmospheric pressure ionization. A disadvantage of DESI is the
variation in ionization due to chemical and/or physical variability in the tissue samples. Because
the sniffer (Fig. 1) is held so close to the tissue surface, we have seen that if the 50 m tissue
slice has ragged edges or variable thickness, the sniffer position relative to the sample surface
changes during a scan, causing biases in the image.
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Imaging lipids is convenient because they ionize well in DESI, and because lipid metabolism lies
at the core of multiple important diseases such as neurodegeneration 2b, 3a, 4, 21 and cancer 5b, 10, 22.
Improved identification of lipids is an important direction for future development in
biochemistry because of their roles in metabolism and signaling. Identification of lipids is
difficult; grouping mass spectral features into (sometimes broad) lipid classes is the current state
of the art 9. For this proof-of-principle study we monitored the turnover of four previously
identified lipids, but the techniques can be applied to any identifiable molecule.
There have been many excellent studies investigating metabolism of lipids in the brain 23. To
our knowledge we are the first to image metabolism of specific lipids. By identifying the
individual lipids, we unlock the ability to investigate the metabolic pathways of each lipid. The
in vivo turnover reports the rate-limiting step for metabolism. Interestingly, use of radiolabeled
AA and DHA has shown that phospholipid incorporation and turnover occurs over a range of
about 2-8% per day 24, in agreement with our observations. The use of radioactivity also
precludes assessment of the percent of the total pool that is synthesized. Using stable isotopes,
the experiment measures turnover rate, as well as the relative contribution of dietary sources to
the metabolism of the tissue. We observed that the PI turnover is faster than the PS, but that there
is a portion of the PI pool within the brain that does not display turnover. This could be due to a
dietary supply of PI, or to brain cells which are preserving the PI in a specific structure. We favor
the dietary supply hypothesis because this 80% limit was uniform across the brain, and both AA
and DHA, which are known to be sourced from the diet to supplement biosynthesis 3a, show
similar trends (Fig. 8).
Both biological and instrumental factors cause variations between images, and in the symmetry
of individual images. As mentioned above, changing ionization efficiency in the DESI source
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introduces variations that are particularly evident in the concentration images. The section of the
brain that is imaged varies somewhat as well because it can be difficult to match the exact
location of the tissue slice within the brain for each time point. The isotope analysis feature of
Image Inspector is valuable for analysis of both biological and instrumental noise. In unlabeled
samples it provides the analyst with an accuracy metric that can be used to evaluate image
quality. Overlapping isotopic signatures can be identified by looking at the intensity patterns
across the brain. For example, there was a significant change in the observed distribution of the
888 m/z neutromer of PI across the brain relative to the monoisotopic 885 m/z (Fig. 10). This
was indicative of an overlapping lipid species, i.e. the low purity of the mass spectrum.
Therefore, the kinetics calculations didn’t include the 888 or heavier m/z neutromers. We also
found that by monitoring bias in the neutromer pattern we have rational criteria for setting signal
thresholds for each analyte in each image. This is a continuous quality analysis which can be
used to rapidly identify noise in the instrument or bias from closely overlapping signals, which
can vary with time or tissue composition.
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Figure 10: Signal purity tested by spatial distribution of neutromers. The isotope pattern of the phosphotidyl
inositol (PI) overlays a second unidentified species at 888.7. The M0-M2 neutromers of PI (885.6, 886.6, 887.6)
have the same distribution (left image). Moving from the left hand side to the right hand side of the 888 peak
produces a very different intensity distribution.

The next step in developing this kinetic imaging method will be to focus on improved
quantitation in combination with the turnover of the individual lipids. This would allow
investigators to distinguish between changes in synthesis, transport, or degradation of lipids.
Expanding the imaging to a wide variety of other analytes, including other metabolites and
proteins, would dramatically expand the utility of this method. This allows us to consider future
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experiments looking into the effect of diet on brain development and health, or investigating the
effect of cancer therapies that target lipid metabolism.
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CHAPTER 5
Conclusion
Addressing age-related diseases is one of the most urgent healthcare needs of our time.
Without a comprehensive understanding of the etiology of aging and its biochemical pathways,
our ability to deal with theses illnesses will be limited. In this dissertation, I addressed one of the
known hallmarks of increasing age, loss of proteostasis, with a novel combined omics
methodology that included an assessment of protein flux within the cell. Combined with
traditional quantitative proteomics and transcriptomics, we were able to gain insight into global
proteostasis, separating the processes of protein synthesis and protein degradation for thousands
of proteins. We applied this methodology to calorie restriction, a model system for aging
studies, and were able to recapitulate many of the known findings regarding calorie restriction,
validating our approach. Global translation was seen to slow, with exceptions for select protein
groups in the mitochondria, endoplasmic reticulum, and secretome. Increasing dietary protein
altered the turnover and quantitative levels of the proteome, demonstrating that calorie restriction
was a result of integrated dietary signaling, with interplay among multiple biochemical
pathways. Transcriptomics enabled us to narrow these changes to post-transcriptional
regulation, and a subsequent focus on protein translation led us to hypothesize a novel model in
which differential degradation of ribosomal subunits (likely resulting from sequestration of the
43S pre-initiation complex into stress granules) contributes to decreased protein synthesis in the
cell, enabling improved proteostasis.
Future experiments will be necessary to test whether this mechanism is correct and
contributes to calorie restriction benefits. While we did gather data on rRNA turnover rates, we
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would need to measure turnover rates for each of the four rRNA molecules in the ribosome to
provide crucial orthogonal data for testing the differential degradation hypothesis. Ribo-SEQ
experiments would provide additional measurements of translational speed, allowing
corroboration of our kinetic proteomics method. Additional longevity studies under identical
conditions would test how well the omic measurements translate to the traditional phenotypic
readouts of calorie restriction regimens. In particular, based on the literature, the addition of
dietary protein and advanced glycation end-products should attenuate calorie restriction induced
longevity; a nutritional geometry-based approach would be expected to be fruitful, especially for
establishing dose dependency. Other organs in the body, such as the brain, kidney, lung, and
spleen, likely react differently to calorie restriction; a comparative analysis between the liver and
these others may uncover alternative pathways of proteostasis modulation under calorie
restriction.
However, further optimization of the current method would probably be necessary to
increase proteome coverage and improve signal-to-noise ratios. In order to ensure high quality
in our data sets, we were forced to discard relatively large numbers of measurements due to
uncertainty and noise. Combined with incomplete proteome coverage, this significantly
decreased overlap between cohort protein data sets, and undermined our ability to make large
numbers of comparisons between individual proteins. Increasing the number and types of
comparative analyses will require much greater overlap in proteome coverage in order to be
meaningful.
But we will eventually want to expand the methodology to incorporate other omics
technologies, such as metabolomics and lipidomics, because it has so much potential. Kinetic
metabolomics would enable the dynamic study of smaller molecules within the cell such as
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amino acids and nucleotides, two species vital for anabolic processes and energy metabolism
within the cell. The expansion of scope to incorporate these smaller, shorter-lived species would
greatly inform our understanding of proteostasis within the cell, and the adaptation of the
methodology would be very straightforward. Indeed, by using deuterated water, we were able to
label multiple molecular species within the cell, and measure the turnover of DNA and lipids in
addition to proteins. We have already shown the feasibility of dynamic lipidomics in our DESIMS study (Chapter 4), opening a new direction in the study of lipid metabolism in brain tissue.
This study also pioneered using kinetics in two-dimensions, which holds great promise for even
greater detailed understanding of the regional differences in the dynamics of metabolism in
tissues.
Ultimately, the goal is to progress to studying aging and age-related diseases in humans
in order to advance clinical diagnostic and therapeutic practices. Since deuterated water is nontoxic in small amounts, the barrier to transfer of the methodology to human studies is low, and
our lab has already begun kinetic proteomic studies in humans. In addition to applications
related to the etiology of aging and its associated diseases, the next step could be studying the
effects of therapeutics designed to delay or reverse aspects of aging. For example, metformin,
resveratrol, aspirin, and rapamycin have all been studied, to one degree or another; an unbiased
combined omics approach including kinetic proteomics may reveal much about pathways of
aging affected, and suggest new therapies. Future application of the methodology in humans
may also make possible personalization of anti-aging therapies to account for differences in
genotype, health, and metabolism.
Clearly, realization of this goal will take time; for now, we still need methodology
development, and more research into the phenomenon of aging. In this dissertation, I have
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described a combined omics methodology that provides a systems-wide view of metabolism
within the cell, with the ability to separate protein synthesis from protein degradation rates, and
discern broad proteomic regulatory levels in just three measurements. This has enabled me to
characterize a previously unreported phenomenon in calorie restriction, and hypothesize a
mechanism that may later become exploitable for therapeutic agents. Combining other omics
technologies with kinetic proteomics has the potential to become foundational for the study of
cellular metabolism, and holds great promise for yielding future scientific insights that lead to
improved human health and lifespan.
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APPENDICES
R Scripts for Data Analysis
Listed below are scripts written in R used to analyze and present the data described in the
preceding chapters. More information on the analyses can be found in the Methods sections for
Chapter 2 and Chapter 3.

RNA-Seq data analysis code
The following code was used to obtain gene counts from RNA-Seq data.
R Code:
# Import Bam files and Assign to features
library(Rsubread)
#This is set up to find all bam files in all subdirectories of set directory
p <- "/Users/richardcarson/Desktop/BYU/Price Lab/RNA Sequencing/Bamfiles/"
f <- list.files(path = p,
pattern = ".bam$",
recursive = T)
f <- paste0(p, f)
rsub <- featureCounts(f,
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annot.ext = "Mus_musculus.GRCm38.86.gtf",
isGTFAnnotationFile = TRUE,
nthreads = 3,
minMQS = 10)
rsubdat <- rsub$counts #extracts the count table from the featurecount object
#name columns
colnames(rsubdat) <- c("h2.1", "C3", "F3", "G3", "C2", "B1", "D2", "e2-3", "H2", "F1",
"B3", "G1", "d2.1", "D1", "A3", "h2.2", "E1", "G2", "A1", "h2.3",
"e2.1", "E2", "C1", "H3", "H1", "B2", "F2", "E3", "A2", "e2.2")
## Get normalized values and filter for diff expressed gens
library(DESeq2)
dds <- DESeqDataSetFromMatrix(countData = rsubdat,
colData = data.frame(Diet=gsub("\\d.*", "", colnames(rsubdat))),
design = ~ Diet)
dds <- DESeq(dds)
# ANOVA-like test
ddsLRT <- nbinomLRT(dds, reduced = ~1)
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rlogvals <- assay(rlog(ddsLRT)) #gets rlog normalized values
r_all_logvals <- rlogvals #this is the data set without filtering for diff-expressed genes
r_all_logvals_filtered <- r_all_logvals[(!is.na(results(ddsLRT)$padj)), ] #filters out NAs
rlogvals <- rlogvals[(!is.na(results(ddsLRT)$padj)) &
results(ddsLRT)$padj < .05
, ] #ANOVA filter applied
colnames(rlogvals) <- colnames(rsubdat)
nrow(rlogvals)

Confidence interval calculator function
Since the majority of the data presented in the previous chapters consists of ratios, either
due to normalization or as comparisons between two different experimental groupings, and the
computation of confidence intervals for ratios of empirical values is non-trivial, I wrote this
function in R, and applied it to all instances when I needed to calculate the 95% confidence
interval of a ratio. I used the following URL’s as references:
https://i.stack.imgur.com/vO8Ip.png and https://stats.stackexchange.com/questions/16349/howto-compute-the-confidence-interval-of-the-ratio-of-two-normal-means (author Harvey
Motulsky).
R Code:
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calculate_CI_Q <- function(x_mean, y_mean, x_SD, y_SD, x_num_meas, y_num_meas) {
# Set the t-ratio based on total degrees of freedom in x and y (for 2 replicates in Quant,
this will be 2 DF), as well as desired confidence (95% standard)
if(!is.na(x_num_meas) && !is.na(y_num_meas)) {
if((x_num_meas+y_num_meas)>2) {
t <- qt(0.975, df=(x_num_meas+y_num_meas-2))
# Calculate the standard errors
if(!is.na(x_SD) && !is.na(y_SD) && !is.na(y_mean)) {
x_SE <- x_SD/(x_num_meas^0.5)
y_SE <- y_SD/(y_num_meas^0.5)
# Calculate an intermediate variable, g
g <- (t*(y_SE/y_mean))^2
}
else
g <- 2
}
else
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# Set g to an arbitrary number greater than 1, since df came out to be less
than 1
g <- 2
# Check to see if the CI of the ratio can be calculated - this is derived from url
references
if(g > 1) {
Outcome <- "Could not be calculated: g > 1"
Q_upper <- "N/A"
Q_lower <- "N/A"
Q_CI_margin <- "N/A"
}
else {
# Calculate the standard error of the quotient
Q_SE <- ((x_mean/y_mean)/(1-g))*((((1g)*(x_SE^2/x_mean^2))+(y_SE^2)/(y_mean^2))^0.5)
# Calculate the confidence interval of the quotient
Q_upper <- ((x_mean/y_mean)/(1-g))+(t*Q_SE)
Q_lower <- ((x_mean/y_mean)/(1-g))-(t*Q_SE)
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Q_CI_margin <- (Q_upper-Q_lower)/2
Outcome <- "Success: g < 1"
}
}
else {
Outcome <- "Could not be calculated: missing values"
Q_upper <- "N/A"
Q_lower <- "N/A"
Q_CI_margin <- "N/A"
}
# Enter the interval into an output construct
ratio <- x_mean/y_mean
CI_function_output <- list(Outcome, Q_upper, Q_lower, Q_CI_margin, ratio)
return(CI_function_output)
}

P-value and Q-value computation for discerning between selective and global regulation
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In order to separate protein data (rate, quantitative MS, RNA-Seq, k-synth, and k-deg)
that was significantly different from the global regulatory shifts observed in Chapter 2 and
Chapter 3, a paired t-test between predicted and measured values was run using the R code
below. In order to correct for false positives arising from multiple comparisons, a q-value test
was also run at a 1% false discovery rate. P-values and q-values were then output to .csv values
for further analyses.
R Code:
# Set up a for-loop to go through and do a t-test by row
library(BSDA)
library(rlang)
library(qvalue)
ttest_data_set_pvalues <- data.frame()
for(i in 1:nrow(ttest_data_set)) {
x_mean <- as.numeric(ttest_data_set[i,2]) #Mean predicted value
s_x <- as.numeric(ttest_data_set[i,3]) #Standard deviation of predicted value
n_x <- as.numeric(ttest_data_set[i,4]) #Number of measurements of the predicted value
y_mean <- as.numeric(ttest_data_set[i,5]) #Mean measured value
s_y <- as.numeric(ttest_data_set[i,6]) #Standard deviation of measured value
n_y <- as.numeric(ttest_data_set[i,7]) #Number of measurements of the measured value
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new_pvalue_test <- tsum.test(x_mean, s_x, n_x, y_mean, s_y, n_y, alternative =
"two.sided", mu=0, var.equal = FALSE, conf.level = 0.95)
new_pvalue <- new_pvalue_test$p.value
if (!is.na(new_pvalue)) {
new_row <- c((ttest_data_set[i,]), new_pvalue)
ttest_data_set_pvalues <- rbind(ttest_data_set_pvalues, t(new_row))
}
print(i)
}
colnames(ttest_data_set_pvalues) <- c(colnames(ttest_data_set), "t_test_p_values")
# Run the q-value test
p_values <- as.list(as.matrix(ttest_data_set_pvalues$t_test_p_values))
# Note: if errors, set pi0=1 for the Benjamini-Hochberg procedure instead
qobj <- qvalue(p = as.vector(p_values, mode = "numeric"), fdr.level = 0.01)

Synthesis and degradation rate constant ontology analyses
Below is the R script used for analyzing the k-synth and k-deg ontology data. While the
computation of k-synth and k-deg values and their confidence intervals is straightforward, the
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ontology analysis data from DAVID required further processing. The following code outputs
gene ontologies that are significantly different between experimental groups, and pairs them with
the k-synth and k-deg values for the lists of genes unique to each category.
R Code:
# R ontology data cleanup
# Import the .csv
k_ontology_data <- read.csv("/Users/richardcarson/Desktop/BYU/Price Lab/Lab Papers/Super
Paper/NIH31 vs
Teklad8604/Ksynth_and_Kdeg_for_JC_grant/Annotations_for_ksynth_and_kdeg_R_import.csv
", stringsAsFactors = FALSE) #Contains ontology data output from DAVID

library(tidyr)
library(plyr)
library(dplyr)

# Initialize global variables
temp_list <- matrix()
cluster_list <- character()
output_ontology_clusters <- matrix()
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# Loop through the data and pull out the unique genes for each annotation cluster
for (i in 1:length(rownames(k_ontology_data))) {
current_gene_list <- k_ontology_data$Genes[i] # Pulls out the unedited list of genes
current_gene_list <- gsub(" ", "", current_gene_list) # Removes white space
current_gene_list <- strsplit(current_gene_list, ",") # Splits the list based on comma
delimiter
current_gene_list <- do.call(rbind, current_gene_list) # Transforms the list into a matrix
temp_list <- cbind(current_gene_list, temp_list) # Adds the list to the previous iteration's
list
temp_list <- unique(temp_list) # Removes duplicates
current_cluster <- k_ontology_data$Annotation_cluster[i]
print(current_cluster)
if (i==length(rownames(k_ontology_data))) { # If at the end of the annotation list,
immediately put the gene list into the output
output_ontology_clusters <- rbind.fill.matrix(output_ontology_clusters,
temp_list) # Attach the list to the output matrix
cluster_list <- c(cluster_list, current_cluster)
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}
else { # If not at the end of the annotation list, continue
next_cluster <- k_ontology_data$Annotation_cluster[i+1]
if(current_cluster != next_cluster) { # Checks to see if the next gene list goes with
the previous one, i.e. has the same annotation cluster designation
output_ontology_clusters <- rbind.fill.matrix(output_ontology_clusters,
temp_list) # Attach the list to the output matrix
temp_list <- matrix() # Resets the list for the next cluster
cluster_list <- c(cluster_list, current_cluster)
}
}
}

# Set the output matrix row names to the cluster_list
output_ontology_clusters <- output_ontology_clusters[-1,] # Deletes the first row of the matrix,
which is all NA
rownames(output_ontology_clusters) <- cluster_list # Assigns cluster numbers to the rows
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# Delete duplicates in the ontology cluster lists
test_output_ontology_clusters <- matrix()
for (i in 1:length(rownames(output_ontology_clusters))) {
temp_row <- list()
temp_row <- output_ontology_clusters[i,]
temp_row <- unique(temp_row)
test_output_ontology_clusters <- rbind.fill.matrix(test_output_ontology_clusters,
t(temp_row))
}
test_output_ontology_clusters <- test_output_ontology_clusters[2:45,]
rownames(test_output_ontology_clusters) <- cluster_list
output_ontology_clusters <- test_output_ontology_clusters

### Pair k-synth and k-deg values with gene names (reference:
https://stackoverflow.com/questions/27171505/loop-for-multiple-vlookup-in-r)
# Input k-synth and k-deg data
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k_synth_and_deg <- read.csv("/Users/richardcarson/Desktop/BYU/Price Lab/Lab Papers/Super
Paper/NIH31 vs Teklad8604/Ksynth_and_Kdeg_for_JC_grant/k-synth_and_kdeg_with_CI_DNA_corrected_for_R_import.csv", stringsAsFactors = FALSE)

# Match the data to the genes:
cluster_ksynth_kdeg_matched <- as.data.frame(t(output_ontology_clusters)) # Transpose the
output and make it a dataframe
colnames(cluster_ksynth_kdeg_matched) <- rownames(output_ontology_clusters)
cluster_list <- names(cluster_ksynth_kdeg_matched)

# Diet A (LP AL):
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "A_ksynth", sep = "_")] <k_synth_and_deg$A_k_synth[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for A_k_synth values
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "A_kdeg", sep = "_")] <k_synth_and_deg$A_k_deg[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for A_k_deg values
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# Diet C (LP DR):
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "C_ksynth", sep = "_")] <k_synth_and_deg$C_k_synth[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for C_k_synth values
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "C_kdeg", sep = "_")] <k_synth_and_deg$C_k_deg[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for C_k_deg values

# Diet F (HP AL):
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "F_ksynth", sep = "_")] <k_synth_and_deg$F_k_synth[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for F_k_synth values
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "F_kdeg", sep = "_")] <k_synth_and_deg$F_k_deg[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for F_k_deg values

# Diet G (HP_DR):
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cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "G_ksynth", sep = "_")] <k_synth_and_deg$G_k_synth[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for G_k_synth values
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "G_kdeg", sep = "_")] <k_synth_and_deg$G_k_deg[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for G_k_deg values

# Ratio of C/A (LP DR/AL):
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "CvA_ksynth", sep = "_")] <k_synth_and_deg$CvA_ratio_ksynth[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for C/A_k_synth values
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "CvA_kdeg", sep = "_")] <k_synth_and_deg$CvA_ratio_kdeg[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for C/A_k_deg values

# Ratio of G/F (HP DR/AL):
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cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "GvF_ksynth", sep = "_")] <k_synth_and_deg$GvF_ratio_ksynth[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for G/F_k_synth values
cluster_ksynth_kdeg_matched[paste("Cluster", cluster_list, "GvF_kdeg", sep = "_")] <k_synth_and_deg$GvF_ratio_kdeg[match(unlist(cluster_ksynth_kdeg_matched[,1:44]),
k_synth_and_deg$ProteinID)] # Makes new columns, one for each cluster, and does a v-lookup
for G/F_k_deg values
### Pull out ontology clusters that are significantly different from each other

# ANOVA test, or Kruskal-Wallis non-parametric ANOVA (kruskal.test()) to start
# For kruskal-wallis test, need to convert to a list of lists; run a FOR loop

data_to_analyze <- select(cluster_ksynth_kdeg_matched, contains("_GvF_kdeg"))
list_to_analyze <- list()
for (i in 1:length(colnames(data_to_analyze))) {
temp_list <- data_to_analyze[,i]
temp_list <- temp_list[!is.na(temp_list)]
list_to_analyze[[i]] <- temp_list
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}
kruskal.test(list_to_analyze) # This works if test is a list of lists with more than 1 element
# Note: CvA-ksynth p-value = 0.02994, CvA-kdeg p-value = 0.04766, GvF-ksynth p-value =
2.538e-10, GvF-kdeg p-value = 4.931e-15.
# To get which clusters are different, do a paired t-test: see t.test (library(stats)) or nonparametric: wilcox.test. Question to answer: which clusters are statistically different between
diet comparisons?
# Set global variables - diets to compare and values (x/y)
dietx <- "G"
diety <- "F"
value_to_compare <- "synth"

# Pull data out of the file - make 2 objects, each with the same number and order of clusters
x <- select(cluster_ksynth_kdeg_matched, contains(paste("_", dietx, "_k", value_to_compare,
sep = "")))
y <- select(cluster_ksynth_kdeg_matched, contains(paste("_", diety, "_k", value_to_compare,
sep = "")))
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# Loop through the columns and do the wilcox.test and t.test for each; append p-values to an
object
ttest_pvalue_results <- data.frame()
cluster_list <- sapply(strsplit(colnames(x), split=paste("_", dietx, sep=""), fixed=TRUE),
function(x) (x[1])) # Pulls out just the cluster numbers for labeling
for (i in 1:length(colnames(x))) {
result <- wilcox.test(x[,i], y[,i], paired = TRUE, conf.level = 0.95, na.rm = TRUE) #
Wilcoxon non-parametric paired t-test
ttest_pvalue_results[i,1] <- cluster_list[i]
ttest_pvalue_results[i,2] <- result$p.value # Get the p-value only
}
colnames(ttest_pvalue_results) <- c("Annotation cluster", "Wilcoxon test p-value")
Linear Regression Statistics
The following tables supply the 95% confidence interval (CI) and p-value statistics for
the linear regression analyses in Chapter 2 (Figure 4 and Figure 5) and Chapter 3 (Figure 2,
Figure 3, and Figure 5). These values were obtained using the summary() and confint()
functions in R.
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Table S1: Regression value statistics for Chapter 2.

Turnover Rates

Comparison

Regression
slope

Slope
Lower
CI

Slope
Upper
CI

Slope p
value

Regression
intercept

Intercept
Lower CI

Intercept
Upper CI

Intercept
p value

LP DR vs.
LP AL

0.7796

0.74576

0.81344

3.64E179

0.018355

0.012596

0.024114

8.18E-10

HP DR vs.
HP AL

0.83055

0.78635

0.87476

1.00E155

0.022875

0.015499

0.030251

2.02E-09

Quantitative MS

Comparison

Regression
slope

Slope
Lower
CI

Slope
Upper
CI

Slope p
value

Regression
intercept

Intercept
Lower CI

Intercept
Upper CI

Intercept
p value

LP DR vs.
LP AL

0.89373

0.85923

0.92823

1.49E273

-0.077118

-0.095892

-0.058345

2.25E-15

HP DR vs.
HP AL

0.99355

0.95588

1.0312

4.97E279

-0.11172

-0.14068

-0.082765

8.69E-14

RNA-Seq

Comparison

Regression
slope

Slope
Lower
CI

Slope
Upper
CI

Slope p
value

Regression
intercept

Intercept
Lower CI

Intercept
Upper CI

Intercept
p value

LP DR vs.
LP AL

0.99753

0.9961

0.99896

0.00E+00

0.018802

0.0074092

0.030195

1.22E-03

HP DR vs.
HP AL

0.98578

0.98406

0.9875

0.00E+00

0.099155

0.085481

0.11283

1.74E-45
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Table S2: Regression value statistics for Chapter 3.

Turnover Rates

Comparison

Regression
slope

Slope
Lower CI

Slope
Upper
CI

Slope p
value

Regression
intercept

Intercept
Lower CI

Intercept
Upper CI

Intercept
p value

CR vs. AL

0.6408

0.60456

0.67704

2.22E134

0.043045

0.036707

0.049383

7.06E35

CR PROT
vs. AL

0.78865

0.74681

0.83049

3.54E139

0.026124

0.019076

0.033172

1.44E12

CR AGE
vs. AL

0.78865

0.74681

0.83049

2.32E151

0.026124

0.019076

0.033172

5.18E01

CR PROT
vs. CR

0.85399

0.80946

0.89851

1.59E152

0.025352

0.017791

0.032913

1.08E10

CR AGE
vs. CR

1.0045

0.96561

1.0434

8.52E205

0.00064617

-0.007046

0.0057537

8.43E01

CR AGE
vs. CR
PROT

0.93759

0.90708

0.9681

2.76E236

0.0039489

0.0012656

0.0091635

1.37E01

Quantitative MS

Comparison

Regression
slope

Slope
Lower CI

Slope
Upper
CI

Slope p
value

Regression
intercept

Intercept
Lower CI

Intercept
Upper CI

Intercept
p value

CR vs. AL

0.39729

0.0023333

0.79224

4.87E-02

0.22072

0.045159

0.39629

1.39E02

CR PROT
vs. AL

0.45092

0.069404

0.83245

2.07E-02

0.054955

-0.11977

0.22968

5.36E01

CR AGE
vs. AL

0.45189

0.11187

0.7919

9.35E-03

0.033405

-0.12265

0.18946

6.74E01

0.94615

0.91766

0.97464

-0.14488

-0.17831

-0.11145

CR PROT

5.26E-

9.12E-

210

vs. CR
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CR AGE
vs. CR

0.97755

0.95525

0.99983

1.54E226

-0.21276

-0.23959

-0.18592

2.35E41

CR AGE
vs. CR
PROT

0.9969

0.95238

1.0414

1.44E130

-0.014775

-0.070064

0.040513

5.99E01

RNA-Seq

Comparison

Regression
slope

Slope
Lower CI

Slope
Upper
CI

Slope p
value

Regression
intercept

Intercept
Lower CI

Intercept
Upper CI

Intercept
p value

CR vs. AL

1.0016

1.0002

1.003

0.00E+00

-0.010582

-0.021673

0.00050949

6.15E02

CR PROT
vs. AL

1.0028

1.0014

1.0042

0.00E+00

-0.014796

-0.025781

-0.0038101

8.30E03

CR AGE
vs. AL

1.0019

1.0006

1.0032

0.00E+00

-0.011121

-0.021269

-0.0009729

3.17E02

CR PROT
vs. CR

1.0007

1.0002

1.0012

0.00E+00

0.00052267

0.0047415

0.0036962

8.08E01

CR AGE
vs. CR

0.99931

0.99875

0.99987

0.00E+00

0.0067089

0.0022161

0.011202

3.43E03

CR AGE
vs. CR
PROT

0.99817

0.99759

0.99874

0.00E+00

0.010607

0.0060107

0.015203

6.14E06
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